Skip to main content Accessibility help

The Dystonias

  • Edith G. McGeer (a1) and Patrick L. McGeer (a1)


Dystonia is a difficult problem for both the clinician and the scientist. It is sufficiently common to be seen by almost all physicians, yet uncommon enough to prevent any physician from gaining broad experience in its diagnosis and treatment. Each case represents a difficult challenge even to the specialist. The basic scientist is faced with investigating a disorder that is without relevant animal models and which is so rare that obtaining suitable tissue for study is a major obstacle. Dystonia may be idiopathic, or associated with lesions from many sources, including a variety of rare diseases. If idiopathic, it may be genetically transmitted or sporadic. If genetically transmitted, it may be generalized or focal, with symptoms varying in different members of the same family. It may be refractory to treatment, or it may respond to any one of a number of individual drugs that have very different mechanisms of action. For idiopathic dystonias, no clear method of genetic transmission has been established and no consistent pathology identified.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The Dystonias
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The Dystonias
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The Dystonias
      Available formats


Corresponding author

Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 1W5


Hide All
1.Fahn, S, Marsderi, CD, Calne, DB, eds. Dystonia 2. Adv Neurol 1988 50 (in press).
2.Jankovic, J, Tolosa, E, eds. Facial Dyskinesias. Adv Neurol 1988; 49: 1538.
3.Jankovic, J, Fahn, S.Dystonie syndromes. In;: Parkinson’s Disease and Movement Disorders, Jankovic, J, Toloso, E, eds., Urban and Schwarzenberg, Baltimore, Maryland, 1988.
4.Koller, WC. Adult-onset foot dystonia. Neurology 1984; 34: 703.
5.Arvidson, B. Transient foot dystonia in an adult woman. Neurology 1985; 35: 615.
6.Sandyk, R. Adult-onset focal dystonia. Neurology 1985; 35: 137.
7.Jankovic, J, Orman, J.Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 1984; 161: 371–6.
8.Elston, JS. Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches (letter). J Psychosom Res 1986; 30: 103.
9.Corbin, D, Williams, AC. Stridor during dystonic phases of Parkinson’s disease. J Neurol Neurosurg Psychiatry 1987; 50: 821–2.
10.Corbin, D, Williams, A, Johnson, AP. Dystonia complicated by respiratory obstruction. J Neurol Neurosurg Psychiatry 1987; 50: 1707.
11.Rosenberg, RN, Nyhan, WL, Coutinho, P, Bay, C. Joseph’s disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol 1978; 21: 3357.
12.Paping, RHL, Annyas, AA, Mouij, JJA, Penning, L.Nasopharyngeal torticollis (Grisel’s syndrome). Ned Tijdschr Geneeskd 1985; 129: 1787–90.
13.Disertori, B, Ducati, A, Piazza, M. Spasmodic torticollis, substantiating Manto syndrome, of possible toxic aethiology, with alterations of brainstem acoustic evoked potentials (BAEPs). Ann dell’ospedale Maria Vittoria di Torino 1982; 25: 320.
14.Disertori, B, Ducati, A, Piazza, M, Pavani, M.Brainstem auditory evoked potentials in a case of “Manto syndrome” or spasmodic torticollis with thoracic outlet syndrome. Ital J Neurol Sci 1982; 3: 359–63.
15.Berardelli, A, Rothwell, JL, Day, BL, Marsden, CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985; 108: 593608.
16.Marsden, CD, Sheeny, MP. Spastic dysphonia, Meige disease and torsion dystonia. Neurology 1982; 32: 1202.
17.Faulstich, ME, Carnrike, CLM, Williamson, DA. Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches. J Psychosom Res 1985; 29: 8994.
18.Garcia-Albea, E, Franch, O, Munoz, D, Ricoy, JR. Bruegel’s syndrome, report of a case with postmortem studies. J Neurol Neurosurg Psychiatry 1981; 44: 437–40.
19.Golper, LAC, Nutt, JG, Rau, MT, Coleman, RD. Focal cranial dystonia. J Speech Hearing Disorders 1983; 48: 128–34.
20.Jankovic, J, Ford, J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983; 13: 402–11.
21.Martinelli, P, Gabellini, AS. Essential tremor and buccolinguofacia dyskinesias. Acta Neurol Scand 1982; 66: 705–8.
22.Jankovic, J, Nutt, JG. Blepharospasm and cranial-cervical dystonia (Meige’s syndrome): familial occurrence. Adv Neurol 1988; 49: 117–23.
23.Tolosa, ES. Clinical features of Meige’s disease (idiopathic orofacial dystonia). Arch Neurol 1981; 38: 147–51.
24.Anon Overuse syndrome in musicians. Med J Aust 1987; 146: 393–4.
25.Fry, JH. Overuse syndrome in musicians – 100 years ago: an historical review. Med J Aust 1986; 145: 620–5.
26.Lederman, RJ. Overuse syndrome in musicians. Med J Aust 1987; 146: 390.
27.Hall, T.Overuse syndrome in musicians. Med J Aust 1987; 146: 390.
28.Pratt, RR. Overuse syndrome in musicians. Med J Aust 1987; 146: 390.
29.Chamagne, P. Functional cramps or functional dystonias in writers and musicians. Ann Chir Main 1986; 5: 148152.
30.Yassa, R. The Pisa syndrome: a report of two cases. Brit J Psychiatry 1984; 146: 93–5.
31.Ekbom, K, Lindholm, H, Ljunberg, L. New dystonic syndrome associated with butyrophenone therapy. Neurology 1972; 202: 94103.
32.Saxena, S. Tardive dystonia and Pisa syndrome. Brit J Psychiatry 1986; 149: 524.
33.Rosenfeld, DB, Miller, RH, Jankovic, J.Spasmodic dysphonia: a neurolaryngeal movement disorder. Am Acad Neurol 1984; PP96.
34.Rosenfeld, DB, Miller, RH, Jankovic, J, Nudelman, H. Persistance of spasmodic dysphonia symptoms following recurrent laryngeal nerve section: an electrodiagnostic evaluation. Am Acad Neurol 1984; PP356.
35.Schaefer, SD. Neuropathology of spasmodic dysphonia. Laryngoscope. 1983; 93: 11831204.
36.Hudgson, P. Writer’s cramp. Br Med J [Clin Res] 1983; 286: 585–6.
37.Marsden, CD. Writer’s cramp. Br Med J (Clin Res] 1983; 286: 1057.
38.Sheehy, MP, Marsden, CD. Writers’ cramp – a focal dystonia. Brain 1982; 105:461–80.
39.Fahn, S. Torsion dystonia: clinical spectrum and treatment. Seminars in Neurol 1982; 2: 316–22.
40.Eldridge, R. The torsion dystonias: literature review and genetic and clinical studies. Neurology 1970; 20: 178.
41.Eldridge, R, Gottleib, R. The primary hereditary dystonia: genetic classification of 768 families and revised estimate of gene frequency, autosomal recessive form, and selected bibliography. Adv Neurol 1976; 14: 457474.
42.Alter, M, Kahana, E, Feldman, S. Differences in torsion dystonia among Israeli ethnic groups. Adv Neurol 1976; 14: 115120.
43.Korczyn, AD, Kahana, E, Zilber, N, Streifler, M, Carasso, R, Alter, M. Torsion dystonia in Israel. Ann Neurol 1980; 8: 387–91.
44.Zilber, N, Korczyn, A, Kahana, E, Fried, K, Alter, M. Inheritance of idiopathic torsion dystonia among Jews. J Med Genet 1984; 21: 1320.
45.Nutt, JG, Muenter, MD, Melton, J, et al.Epidemiology of dystonia in Rochester, Minnesota. Adv Neurol 50 1988; (in press).
46.Marsden, CD, Lieberman, AN. Involuntary movement disorders: treatment and prevention. Clin Neuropharmacol 1986; 9(Suppl 2): S1-S121.
47.Obeso, JA, Rothwell, JC, Lang, AE, Marsden, CD. Myoclonic dystonia. Neurology 1983; 33: 825–30.
48.Lang, AE. Dopaminergic agonists in the treatment of dystonia. Clin Neuropharmacol 1985; 8: 3857.
49.Eldridge, R, Ince, SI, Chernow, B, Milstein, S, Lake, CR. Dystonia in 61-year-old identical twins: observations over 45 years. Ann Neurol 1984; 16: 356–8.
50.Wachtel, RCD, Batshaw, ML, Eldridge, R, Jankel, W, Cataldo, M. Torsion dystonia. John Hopkins Medical J 1982; 151: 355–9.
51.Eldridge, R, Koerber, T. Torsion dystonia: autosomal recessive form. In: Genetic Disorders Among Ashkenazi Jews, Goodman, RM, Motulsky, AG, eds., Raven Press, NY, 1979; pp 231–51.
52.Johnson, W, Schwartz, G, Barbeau, A. Studies on dystonia musculorum deformans. Arch Neurol 1962; 7: 301–18.
53.Zeman, W, Dyken, P. Dystonia musculorum deformans. In: Handbook of Clinical Neurology, vol 6, Vinken, PJ, Bruyn, GW eds., Elsevier/North Holland Biomedical Press, Amsterdam, 1981; pp 517–43.
54.Eldridge, R.Inheritance of torsion dystonia in Jews. Ann Neurol 1981; 10: 203–4.
55.Batshaw, ML, Wachtel, R, Eldridge, R. Letter to the Editor. New Eng J Med 1985; 313: 1088.
56.Bressman, SB, de Leon, D, Brin, MF. Inheritance of primary torsion dystonia among Ashkenazi Jews. Neurology 1987; 37(Suppl 1): 187.
57.Oswald, A, Silber, M, Goldblatt, J. Autosomal recessive idiopathic torsion dystonia in kindred of mixed ancestry. S Afr Med 1986; J 69: 1820.
58.Lisker, R, Mutchinick, O, Reyes, ME, Santos, MA, Flores, T, Ramos, GG. Autosomal recessive inheritance in a Mexican family with torsion dystonia. Rev Invest Clin (Mex) 1984; 36: 265–8.
59.Bressman, SB, Fahn, S, Falk, C, Allen, FH Jr, Suciu-Foca, N. Genetic linkage analysis in primary torsion dystonia. Neurology 1984; 34: 14901493.
60.Breakefield, XO, Bressman, SB, Kramer, PL, et al.Linkage analysis in a family with dominantly inherited torsion dystonia: exclusion of the pro-opiomelanocortin and glutamic acid decarboxylase genes and other chromosomal regions using DNA polymorphisms. J Neurogenet 1986; 3: 159–75.
61.Harris, EG. Conference report. The torsion dystonias: a summary of the Third Dystonia Workshop, Vancouver, B.C., 1980. Can J Neurol Sci 1981; 8: 255–7.
62.Martinez-Martin, P, Pareja, FB. Familial writer’s cramp. J Neurol Neurosurg Psychiatry 1985; 48: 4.
63.Nutt, JG, Hammerstad, JP. Blepharospasm and oromandibular dystonia (Meige’s syndrome) in sisters. Ann Neurol 1981; 9: 189–91.
64.Theau, D, Missoum, A. Syndrome dystonique severe traité avec succès par la bromocriptine et syndromes d’ataxie-télangiectasie dans une même famille. Arch Fr Pediatr 1986; 43: 535–8.
65.Jankovic, J, Penn, AS. Severe dystonia and myoglobinuria. Neurology 1982; 32: 1195–7.
66.Rosenbaum, F, Jankovic, J. Focal task-specific tremor and dystonia. Neurology 1988; 38: 522–7.
67.Bundey, S, Harrison, MJG, Marsden, CD. A genetic study of torsion dystonia. J Med Genet 1975; 12: 12.
68.Kiwak, KJ. Establishing an etiology for torticollis. Postgrad Medicine 1984; 75: 126–34.
69.Lee, MC. Spasmodic torticollis and other idiopathic torsion dystonias. Postgrad Med 1984; 75: 139–45.
70.Naber, D, Weinberger, DR, Bullinger, M, Polsby, M, Chase, TN. Spasmodic torticollis. A study of symptoms, course, family history and psychopathology. Nervenarzt 1986; 57: 238–43.
71.Gauthier, S. Idiopathic spasmodic torticollis: pathophysiology and treatment. Can J Neurol Sci 1986; 13: 8890.
72.Martinelli, P, Gabellini, AS, Culli, MR, Lugaresi, E. Different clinical features of essential tremor: a 200-patient study. Acta Neurol Scand 1987; 75: 106–11.
73.Mart’inez-Mart’in, P. Epidemiological aspects of essential tremor. Arch Neurobiol (Madr) 1985; 48: 189–95.
74.Bolton, PS. Torticollis: a review of etiology, pathology, diagnosis and treatment. J Manipulative Physiol Therapies 1985; 8: 2932.
75.Gilmore, R. Movement disorders in the elderly. Geriatrics 1984; 39: 65–8, 72–6.
76.Segawa, M, Ohmi, K, Ito, S, et al.Childhood basal ganglia disease with remarkable responses to L-DOPA, “hereditary basal ganglia disease with marked diurnal fluctuation”. Therapy 1971; 24: 667–72.
77.Segawa, M, Hosaka, A, Miyagawa, F. et al.Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurology 1976; 14:215–33.
78.Haidvogl, M, Stogmann, W. Hereditäre progressive Dystonie mit Tagesschwankunger. Jahrestag fur Osterreichischen Gesellschaft fur Kinderheilkunde, Millstatt, 1976; 24, 9 (abstract).
79.Ouvrier, RA. Progressive dystonia with marked diurnal fluctuation. Ann Neurol 1978; 4: 412–7.
80.Chan-Lui, WY, Low, LCK. Progressive dystonia with marked diurnal fluctuation in a Chinese family. Aust Paediatr J 1984; 20: 143146.
81.Chan-Lui, WY, Low, LCK. A patient with myasthenia gravis and progressive dystonia with marked diurnal fluctuation. Dev Med Child Neurol 1984; 26: 665668.
82.Bertelsmann, FW, Smit, LME. Progressive dystonia with marked diurnal fluctuation. Clin Neurol Neurosurg 1985; 87: 123126.
83.Gordon, N.Fluctuating dystonia and allied syndromes. Neuropediatrics 1982; 13: 152–4.
84.Deonna, T. Dopa-sensitive progressive childhood dystonia with diurnal fluctuations. (Segawa type and possible variants). Results of a correspondence workshop of the E.F.C.N.S. Meeting of the E.F.C.N.S. Noordwijkerhout 1983.
85.Schenk, E, Kruschke, U. Familial progressive Dystonie mit Tageschwankungen – Erfolgreiche Behandlung mit L-dopa. Klin Wschr 1975; 53: 779780.
86.Yamamura, Y, Sobne, I, Ando, K, Iida, M, Yanagi, T, Kono, C. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 1978; 23: 239–44.
87.Sunohara, N, Mano, Y, Ando, K, Satoyoshi, E. Idiopathic dystonia parkinsonism with marked diurnal fluctuation of symptoms. Ann Neurol 1985; 17: 3945.
88.Aggarwal, R, Bagga, A, Kalra, V. Progressive dystonia with marked diurnal variation. Indian J Pediat 1984; 51: 747749.
89.Kumamoto, I, Nomoto, M, Yoshidome, H, Osarne, M, Igata, A. Five cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF. Rinsho Shinkeigaku (Clinical Neurology) 1984; 24: 697702.
90.Deonna, T, Ferreria, A. Idiopathic fluctuating dystonia: a case of foot dystonia and writer’s cramp responsive to L-dopa. Dev Med Child Neurol 1985;27:814821.
91.Costeff, H, Gadoth, N, Mendelson, L, Harel, S, Lavie, P. Fluctuating dystonia response to levodopa. Arch Dis Childhood 1987; 62: 801–4.
92.Nygaard, TG, Marsden, D. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1988; 38(Suppl 1): 130.
93.Fink, JK, Baron, N, Cohen, W, Lovenberg, W, Burns, RS, Halle’, M. Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 1988; 38: 707–11.
94.Nygaard, T, Duvoisin, R. Hereditary dystonia-parkinsonism syndrome of juvenile onset. Neurology 1986; 36: 1424–8.
95.Deonna, T. DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms – Segawa’s syndrome and possible variants. Neuropediatrics 1986; 17: 8185.
96.Lance, JW. Sporadic and familial varieties of tonic seizures. J Neurol Neurosurg Psychiatry 1963; 26: 51–9.
97.Lance, JW. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 1977; 2: 283–95.
98.Mount, LA, Reback, S. Familial paroxysmal choreoathetosis: preliminary report on a hitherto undescribed clinical syndrome. Arch Neurol Psychiatry 1940; 44: 841–7.
99.Forssman, H. Hereditary disorder characterized by attacks of muscular contractions, induced by alcohol amongst other factors. Acta Med Scand 1961; 170: 517–33.
100.Kurlan, R, Shoulson, I. Familial paroxysmal dystonic choreoa thetosis and response to alternate-day oxazepam therapy. Ann Neurol 1983; 13:456–7.
101.Richards, RN, Barnett, HJM. Paroxysmal dystonic choreoathetosis: a family study and review of literature. Neurology 1968; 18: 461–9.
102.Mayeux, R, Fahn, S. Paroxysmal dystonic choreoathetosis in a patient with familial ataxia. Neurology 1982; 32: 1184–6.
103.Graff-Radford, NR. A recessively inherited ataxia with episodes of dystonia. J Neurol Neurosurg Psychiatry 1986; 49: 591–4.
104.Plant, GT, Williams, AC, Earl, CJ, Marsden, CD. Familial paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry 1984; 47: 275–9.
105.Willemse, J. Benign idiopathic dystonia with onset in the first year of life. Dev Med Child Neurol 1986; 28: 355–60.
106.Deonna, T, Martin, D. Benign paroxysmal torticollis in infancy. Arch Dis Child 1981; 56: 956959.
107.Hanukoglu, A, Somekh, E, Fried, D. Benign paroxysmal torticollis in infancy. Clin Ped 1984 23: 272–4.
108.Dunn, DW. Paroxysmal dystonia. Am J Dis Child 1981; 135: 381.
109.De Benedetto, F. Il torcicollo parossistico benigno nell’infanzia. Min Ped 1980; 9: 647.
110.Militerni, R, Tripodi, V, D’Argenzio, G, Quinto, AM. A case of paroxysmal torticollis. Pediatria 1983; 91: 265–7.
111.Casteels-Van Daele, M. Benign paroxysmal torticollis in infancy. Arch Dis Childhood 1982; 57: 638642.
112.Lugaresi, F, Cirignotta, F, Montagna, P. Nocturnal paroxysmal dystonia. J Neurol Neurosurg Psychiatry 1986; 49: 375–80.
113.Crowell, JA, Anders, TF. Hypnogenic paroxysmal dystonia. J Amer Acad Child Psychi 1985; 24: 353358.
114.Lee, BI, Lesser, RP, Pippenger, CE, et al.Familial paroxysmal hypnogenic dystonia. Neurology 1985; 35: 1357–60.
115.Berger, HJC, Berendsen-Versteeg, TMC, Joosten, EMG. Hypnogenic, paroxysmal dystonia: epilepsy or a new syndrome? Ned Tijdschr Geneeskd 1984; 128: 16971698.
116.Godbout, R, Montplaisir, J, Rouleau, I. Hypnogenic paroxysmal dystonia: epilepsy or sleep disorder. A case report. Clin Electroencephalog 1985; 16: 136–42.
117.Lugaresi, E, Cirignotta, F. Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome. Sleep 1981; 4: 129–38.
118.Healton, EB, Brust, JC, Kerr, DL, Resor, S, Pern, A. Presumably Azorean disease in a presumably non-Portuguese family. Neurology 1980; 30: 1084–9.
119.Goto, I, Tobimatsu, S, Ohta, M, Hoisokawa, S, Shibasaki, H, Kuroiwa, Y. Dentatorubropallidoluysian degeneration: clinical, neuroophthalmologic, biochemical and pathologic studies on autosomal dominant form. Neurology 1982; 32: 1395–9.
120.Hotson, JR, Langston, EB, Louis, AA, Rosenberg, RN. The search for a physiologic marker of Machado-Joseph disease. Neurology 1987; 37: 112–6.
121.Sachdev, HS, Forno, LS, Kane, CA. Joseph disease: a multisystem degenerative disorder of the nervous system. Neurology 1982; 32: 192–5.
122.Grossman, A, Rosenberg, RN, Warmouth, L. Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology 1987; 37: 106111.
123.Luchins, DJ, Goldman, M. High-dose bromocriptine in a case of tardive dystonia. Biol Psychiatry 1985; 20: 179–1.
124.Watts, RWE, Harkness, RA, Spellacy, E, Taylor, NF. Lesch-Nyhan syndrome: growth delay, testicular atrophy and a partial failure of the 11β-hydroxylation of steroids. J Inher Metab Dis 1987; 10: 210–23.
125.Watts, RWE, Spellacy, E, Gibbs, DA, Allsop, J, McKeran, RO, Slavin, GE. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the neurological manifestations. QJ Med 1982; 51: 4378.
126.Craig, IW, Goodfellow, PN. Molecular genetics of the X chromo some and X-linked diseases. Lab Invest 1986; 54: 241253.
127.Goeminne, L. A new probable X-linked inherited syndrome: congenital torticollis, multiple keloids, cryptorchidism and renal dysplasia. Acta Henet Med Gemellol 1968; 17: 439467.
128.Zuffardi, O, Fraccaro, M. The locus for torticollis, keloids, cryptorchidism and renal dysplasia (31430 McKusick) is at Xq28, distal to the G6PD locus. Hum Genet 1982; 62: 280–1.
129.Chance, PF, Murray, JC, Bird, TD, Kochin, RS. Genetic linkage relationships of Charcot-Marie-Tooth disease (HMSN-Ib) to chromosome I markers. Neurology 1987; 37: 325329.
130.Leblhuber, F, Reisecker, F, Mayr, WR. Genetic linkage studies in hereditary motor and sensory neuropathies. J Neurol 1986; 233: 317–9.
131.Philippart, M, Brown, WJ. Dystonia and lactic acidosis: new features of Rett’s syndrome. Ann Neurol 1984; 16: 387.
132.The Rett Syndrome Criteria Work Group Diagnostic criteria for Rett syndrome. Ann Neurol 1988; 23: 425–8.
133.DeGennaro, LJ, McCaffery, CA, Kirchgessner, CU, Yang-Feng, TL, Francke, U. Molecular analysis of synapsin 1, a candidate gene for Rett syndrome. Brain Dev 1987; 9: 469–74.
134.Torch, WC, Humphreys, HK. Pharmacological therapy of Hallervorden-Spatz syndrome: two cases responsive to ben-ztropine. Ann Neurol 1986; 20: 445.
135.Kessler, C, Schwechheimer, K, Reuther, R, Born, JA. Hallervorden Spatz syndrome restricted to the pallidal nucleus. J Neurol 1984; 231: 112–6.
136.Sethi, KD, Adams, RJ, Loring, DW, ElGammal, T. Clinical, neuropsychological and magnetic resonance imaging in Hallervorden-Spatz syndrome. Ann Neurol 1987; 22: 146–7.
137.Tennison, MB, Bouldin, TW, Whaley, RA. Mineralization of the basal ganglia detected by CT in Hallervorden-Spatz syndrome. Neurology 1988; 38: 154155.
138.Swaiman, KF, Smith, SA, Trock, GL, Siddiqui, AR. Sea-blue histiocytes, lymphocytic cytosomes, movement disorder and 59Fe-uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan. Neurology 1983; 33: 301–5.
139.Di Rocco, M. Dystonia and calcification of the basal ganglia: another case. Neurology 1986; 36: 306.
140.Alberca, R, Rafel, E, Chinchón, I, Vadillo, J, Navarro, A. Late onset Parkinsonian syndrome in Hallervordeen-Spatz disease. J Neurol Neurosurg Psychiatry 1987; 50: 1665–8.
141.Perry, TL, Norman, MG, Yong, VW, Whiting, S, Crichton, JU, Hansen, S, Kish, SJ. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 1985; 18: 482–9.
142.Jankovic, J, Kirkpatrick, JB, Blomquist, KA, Langlais, PJ, Bird, ED. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology 1985; 35: 227–34.
143.Walters, GF, Brucher, JM, Martin, JJ, Ceuterick, C, Pilz, P, Freund, M. Leigh’s syndrome - several nosological entities with an identical histopathological complex? Neuropath Appi Neurobiol 1986; 1:95107.
144.Gallego, J, Obeso, JA, Delgado, G, Villanueva, JA. Leigh disease with torsion dystonia as the sole clinical manifestation. Arch Neurobiol 1986; 49: 73–8.
145.Rondot, P, de Recondo, J, Davous, P, Fredy, D, Rous, F. Rigidité extra-pyramidale avec dystonie, atrophie optique et atteinte bilaterale du putamen chez un adolescent. Forme juvenile de la maladie de Leigh. Rev Neurol (Paris) 1982; 128: 143–8.
146.Campistol, J, Cusi, V, Vernet, A, Fernandez-Alvarez, E. Dystonia as a presenting sign of subacute necrotising encephalomyelopathy in infancy. Eur J Pediatr 1986; 144: 589591.
147.Burton, K, Farrell, K, Li, D, Calne, DB. Lesions of the putamen and dystonia: CT and magnetic resonance imaging. Neurology 1984; 34: 962965.
148.Bianco, F, Floris, R, Pozzassere, G, Rizzo, PA. Subacute necrotizing encephalopathy (Leigh’s disease): clinical correlations with computerized tomography in the diagnosis of the juvenile and adult forms. Acta Neurol Scand 1987; 75: 214217.
149.Marsden, CD, Lang, AE, Quinn, NP, et al.Familial dystonia and visual failure with striatal CT lucencies: J Neurol Neurosurg Psychiatry 1986; 49: 500–9.
150.Kissel, JT, Kolkin, S, Chakeres, D, Boesel, C, Weiss, K. Magnetic resonance imaging in a case of autopsy-proved adult subacute necrotizing encephalomyelopathy (Leigh’s disease). Arch Neurol 1987; 44: 563–6.
151.van Erven, PMMM, Gabreels, FJM, Ruitenbeek, W, Renier, WO, Lamers, KJB, Sloof, JL. Familial Leigh’s syndrome: association with a defect in oxidative metabolism probably restricted to brain. J Neurol 1987; 234: 215–9.
152.Di Mauro, S, Zeviani, M, Servidei, S, et al. Cytochrome oxidase deficiency: clinical and biochemical heterogeneity. Ann NY Acad Sci 1986; 488: 1932.
153.Miyabayashi, S, Ito, T, Abukawa, D, et al.Immunochemical study in three patients with cytochrome c oxidase deficiency presenting Leigh’s encephalomyelopathy. J Inher Metab Dis 1987; 10: 289–92.
154.Ushiyama, M, Hanyu, N, Ikeda, S, Yanagisawa, N. A case of type III (adult) GMl-gangliosidosis that improved markedly with trihexyphenidyl. Rinsho Shinkeigaku 1986; 26: 221–7.
155.Nakano, T, Ikeda, S, Kondo, K, Yanagisawa, N, Tsuji, S. Adult GMl-gangliosidosis: clinical patterns and rectal biopsy. Neurology 1985; 35: 875–80.
156.Takamoto, K, Beppu, H, Hirose, K, Uono, M. Juvenile beta-galactosidase deficiency – a case with mental deterioration, dystonic movements, pyramidal symptoms, dysostosis and cherry red spot. Rinsho Shinkeigaku 1980; 20: 339–45.
157.Oates, CE, Bosch, EP, Hart, MN. Movement disorders associated with chronic Gj gangliosides. Eur Neurol 1986; 25: 154–9.
158.Meek, D, Wolfe, LS, Andermann, E, Andermann, F. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. Ann Neurol 1984; 15: 348–52.
159.Hardie, RJ, Young, EP, Morgan-Hughes, JA. Hexoseaminidase A: deficiency presenting as juvenile progessive dystonia. J Neurol Neurosurg Psychiatry 1988; 51: 446–7.
160.Halperin, JJ, Williams, RS, Kolodny, EH. Microcephaly vera, progressive motor neuron disease and nigral degeneration. Neurology 1982; 32: 317–20.
161.Elwes, R, Saunders, M. Generalised dystonia, whispering dysphonia and Wilson’s disease in members of the same family. J Neurol Neurosurg Psychiat 1986; 49: 107.
162.Bodensteiner, JB, Goldblum, RM, Goldman, AS. Progressive dystonia masking ataxia in ataxia-telangiectasia. Arch Neurol 1980; 37: 464–5.
163.Ferrannini, E, Perniola, T, Krajewska, G, Serlenga, L, Trizio, M. Schwartz-Jampel syndrome with autosomal-dominant inheritance. Eur Neurol 1982; 21: 137–46.
164.Yatziv, S, Russell, A. An unusual form of metachromatic leukodystophy in three siblings. Clin Genet 1981; 19: 222–7.
165.Lang, AE, Clarke, JTR, Resch, L, Strasberg, P, Skomorowski, MA, O’Connor, P. Progressive long-standing “pure” dystonia: a new phenotype of juvenile metachromatic leukodystrophy (MLD). Neurology 1985; 35 (Suppl I): 194.
166.Poll-The, BT, Aicardi, J, Girot, R, Rosa, R. Neurological findings in triosephosphate isomerase deficiency. Ann Neurol 1985; 17: 439–43.
167.Davous, P, Rondot, P. Homocystinuria and dystonia. J Neurol Neurosurg. Psychiatry 1983; 46: 283.
168.Hagberg, R, Hambraeus, L, Bensch, K. A case of homocystinuria with a dystonic neurological syndrome. Neuropadiatrie 1970; 1: 337–43.
169.Hellstrom, B. Progressive dystonia and dyskinesia in childhood. A review of some recent advances. Acta Paediatr Scand 1982; 71: 177–81.
170.Amir, N, El-Peleg, O, Shalev, RS, Christensen, E. Glutaric aciduria type I: clinical heterogeneity and neuroradiologic features. Neurology 1987; 37: 1654–7.
171.Leibel, RL, Shih, VE, Goodman, SI, et al.Glutaric acidemia: a metabolic disorder causing progressive choreoathetosis. Neurology 1980; 30: 1163–8.
172.Aicardi, J, Goutieres, F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984; 15: 4954.
173.Korf, B, Wallman, JK, Levy, HL. Bilateral lucency of the globus pallidus complicating methylmalonic acidemia. Ann Neurol 1986; 20: 364–6.
174.Tahmoush, AJ, Alpers, DH, Feigin, RD, Armbrustmacher, V, Prensky, AL. Hartnup disease. Arch Neurol 1976; 33: 797807.
175.Darras, BT, Gilmore, HE. Focal intermittent dystonia in Hartnup disease. Ann Neurol 1985; 18: 397–8.
176.Breen, LA, Schochet, SS Jr.Adult dystonic lipidosis. Neurology 1984; 34: 128–9.
177.Longstreth, WT, Daven, JR, Farrell, DF, Bolen, JW, Bird, TD. Adult dystonic lipidosis: clinical, histologic, and biochemical findings of a neurovisceral storage disease. Neurology 1982; 32: 1295–9.
178.Martin, JJ, Lowenthal, A, Ceuterick, C, Vanier, MT. Juvenile dystonic lipidosis (variant of Niemann-Pick disease type C). J Neurol Sci 1984; 66: 3345.
179.Miyajima, H, Nishimura, Y, Mizoguchi, K, Sakamoto, M, Shimizu, T, Honda, N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987; 37: 761–7.
180.Starosta-Rubinstein, S, Young, AB, Kluin, K, et al.Clinical assessment of 31 patients with Wilson’s disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987; 44: 365–70.
181.Hawkins, RA, Mazziotta, JC, Phelps, ME. Wilson’s disease studied with FDG and positron emission tomography. Neurology 1987; 37: 1707–11.
182.Parker, N. Hereditary whispering dysphonia. J Neurol Neurosurg. Psychiatry 1985; 48:218–24.
183.Hirabayashi, S-i, Kanda, H, Kurata, S, Yanagisawa, N. Effects of trihexyphenidyl in a patient with symptomatic dystonia secondary to Wilson’s disease. Brain & Devel 1985; 7: 230.
184.Brewer, GJ, Terry, CA, Aisen, AM, Hill, GM. Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch Neurol 1987; 44: 490–3.
185.Fazio, C, Agnoli, A, Perissinotti, E. Distonia attituudinale e torcicollo spastico associati ad un aumento dell cupruria. Minerva Med 1968; 59: 3359–68.
186.Agnoli, A, Casacchia, M, Fieschi, C. Aspetti clinici della degenerazione epatolenticolare. Studio del “turnover” del rame in alcune sindromi extrapiramidali. Recent Progr Med (Roma) 1970; 49: 385–98.
187.van Bogaert, L. Etudes anatomocliniques sur des dystonies de torsion d’origine hepatolenticulaire et d’oridine abiotrophique dans la même famille. Monatschr Psychiat Neurol 1947; 114:331–56.
188.De Lellis, M, Rosini, MP, Frascarelli, M, Palladini, G. Un caso dispasmo di torsione. Studio morfologico e biochimico. Acta Neurol 1976; 31: 100103.
189.Pall, HS, Williams, AC, Blake, DR, Winyard, P, Chirico, S, Brailsford, S. Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants. J Neurol Neurosurg Psychiatry 1987; 50: 1234–5.
190.Rust, RS, Noetzel, MJ, Rosenblum, JL, Rothbaum, RJ, Keating, JP. An unusual movement disorder associated with tyrosinosis and elevated cerebrospinal fluid catecholamines. Ann Neurol 1985; 18: 399.
191.Kristensen, MO. Progressive supranuclear palsy – 20 years later. Acta Neurol Scand 1985; 71: 177–89.
192.Rafal, RD, Friedman, JH. Limb dystonia in progressive supranuclear palsy. Neurology 1987; 37: 1546–9.
193.Leger, JM, Girault, JA, Bolgert, F. Isolated dystonia of an upper limb as the first sign of Steele-Richardson-Olszewski disease. Rev Neurol 1987; 143: 140–2.
194.Janati, A. Progressive supranuclear palsy: report of a case with torticollis, blepharospasm and dysfluency. Am J Med Sci 1986: 292: 391–2.
195.Sieradzan, K, Kwiecinski, H, Sawicka, E. Progressive supranuclear palsy with lower motor neuron involvement. J Neurol 1987; 234: 247250.
196.Tanner, CM, Goetz, CG, Klawans, HL. Multi-infarct, PSP. Neurology 1987; 37: 1819.
197.Moses, H, Zee, D. Multi-infarct PSP. Neurology 1987; 37: 1819.
198.Sandyk, R. Excessive yawning and progressive supranuclear palsy. Int J Neurosci 1987; 34: 123–4.
199.Wimalaratna, HSK, Capildeo, R. Is yawning a brainstem phenomenon? Lancet 1988; 1: 300.
200.Foster, NL. Progressive supranuclear palsy and hyperkalemic periodic paralysis. Arch Neurol 1980; 37: 461–2.
201.Lees, AJ, Hardie, RJ, Stern, GM. Kinesigenic foot dystonia as a presenting feature of Parkinson’s disease. J Neurol Neurosurg Psychiatry 1984; 47: 885.
202.Poewe, WH, Lees, AJ, Stern, GM. Dystonia in Parkinson’s disease: clinical and pharmacological features. Ann Neurol 1988; 23: 7378.
203.Katchen, M, Duvoisin, RC. Parkinsonism following dystonia in three patients. Movement Disorders 1986; 1: 151–7.
204.Poewe, WH, Lees, AJ, Stern, GM. Dystonia in Parkinson’s disease: clinical and pharmacological features. Ann Neurol 1988; 23: 738.
205.Frankel, M, Cummings, JL. Neuro-ophthalmic abnormalities in Tourette’s syndrome: functional and anatomic implications. Neurology 1984;34:359–61.
206.Feinberg, TE, Shapiro, AK, Shapiro, E. Paroxysmal myoclonic dystonia with vocalizations: new entity or variant of preexisting syndromes? Neurol Neurosurg Psychiatry 1986; 49: 52–7.
207.De Reuck, J, Van Landegem, W. The posterior crico-aryternoid muscle in two cases of Shy-Drager syndrome with laryngeal stridor. J Neurol 1987; 234: 187190.
208.Berger, JR, Sheremata, WA, Melamed, E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol 1984; 41: 747750.
209.Jankovic, J, Patel, SC. Blepharospasm associated with brainstem lesions. Neurology 1983; 33: 1237–40.
210.Grafton, ST, Bahls, F, Bell, KR. Acquired dystonia following central pontine myelinolysis. Neurology 1987; 37 (Suppl I): 276.
211.Schwartz, M, Selhorst, J, Ochs, A, et al.Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple’s disease. Ann Neurol 1986; 20: 677–83.
212.Ferrarini, G, Greco, G, Guidetti, D, Bragaglia, MM, Zueco, R. Baratti, M. Paraneoplastic myelo-radiculo-neuropathy with dystonic manifestations. Riv Neurobiol 1984; 30: 555–61.
213.Piper, HF. Nystagmus and torticollis in albinism. Klin Mbl Augenheilk 1980; 176: 782–91.
214.Baraitser, M. A new camptodactyly syndrome. J Med Genet 1982; 19:4043.
215.Aver’ianov, IuN, Il’ina, NA, Nechkina, NP, Sokolina, NA, Potomskaia, LZ. Ophthalmoplegia-plus (multisystem mitochondrial cytopathy) in childhood. Zh Nevropatol Psikiatr 1983; 83: 1624–8.
216.Novotny, EJ Jr, Singh, G, Wallace, DC, et al.Leber’s disease and dystonia: a mitochondrial disease. Neurology 1986; 36: 1053–60.
217.Browne, JL, Hart, RR. Exacerbation of tardive dyskinesia by Joseph disease. J Clin Psychiatry 1986; 47: 315316.
218.Roytta, M, Olsson, I, Sowander, P, Svendsen, P. Infantile bilateral striatal necrosis: clinical and morphological report of a case and a review of the literature. Acta Neuropathol (Beri) 1981; 55: 97103.
219.Goutieres, F, Aicardi, J. Acute neurological dysfunction associated with destrucive lesions of the basal ganglia in children. Ann Neurol 1982; 12: 328–32.
220.Paterson, D, Carmichael, EA. A form of familial cerebral degeneration chiefly affecting the lenticular nucleus. Brain 1924; 47: 207–31.
221.Miyoshi, K, Matsuoka, T, Mizushima, A. Familial holotopistic striatal necrosis. Acta Neuropathol (Beri) 1969; 13: 240.
222.Roessmann, U, Schwartz, JF. Familial striatal degeneration. Arch Neurol 1973; 29: 314–7.
223.Pebenito, R, Ferretti, C, Chandry, RR, Woodrow, PK. Idiopathic torsion dystonia associated with lesions of the basal ganglia. Clin Pediatr 1984; 23: 232–5.
224.Lang, AE, Quinn, NP, Marsden, CD. Hereditary generalized dystonia with symmetrical striatal lucencies: a probable form of Leigh’s disease. Neurology 1984; 34 (suppl 1): 236.
225.Bargeton-Farkas, E, Cochard, AM, Brissaud, HE, Robain, O, LeBalle, JC. Encephalopathie infantile familiale avec necrose bilaterale et symmetrique des corps stries. J Neurol Sci 1964; 1: 429445.
226.Tudehope, DI, Burns, YR, O’Callaghan, M, Mohay, H. Minor neurological abnormalities during the first year of life in infants of birth weight less than 1500 g. Aust Paediatr J 1981; 17:265–8.
227.Burke, RE, Fahn, S, Gold, AP. Delayed-onset dystonia in patients with “static” encephalopathy. J Neurol Neurosurg Psychiatry 1980; 43:789797.
228.Obeso, JA, Vaamonde, J. Barraquer-Bordas, L. Delayed onset dystonia. J Neurol Neurosurg Psychiatry 1985; 48: 1190–1.
229.Burke, RE, Fahn, S, Marsden, CD, Bressman, SB, Moskowitz, C, Friedman, J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35: 73–7.
230.Treves, T, Korczyn, AD. Progressive dystonia and paraparesis in cerebral palsy. Eur Neurol 1986; 25: 148–53.
231.Kyllerman, M. Reduced optimality in pre- and perinatal conditions in dyskinetic cerebral palsy – distribution and comparison to controls. Neuropediatrics 1983; 14: 2936.
232.Kyllerman, M, Bager, B, Bensch, J, Bille, B, Olow, I, Voss, H. Dyskinetic cerebral palsy. I. Clinical categories, associated neurological abnormalities and incidences. Acta Paediatr Scand 1982; 71: 543–50.
233.Boiten, J, Hageman, G, de Graaff, R. The conservative treatment of patients presenting with Grisel’s syndrome. Clin Neurol Neurosurg 1986; 88: 95–9.
234.Pinelli, G, Piantanida, M, Roffo, A, Baldini, A, Bonioli, E. Grisel’s syndrome in paediatric age. Min Ped 1981; 33: 3941.
235.Stevanovic, L, Weber, S. Retropharyngeal abscess as a cause of cervical spine syndrome. Schweiz Rundschau Med 1986; 75: 585–9.
236.Neng, T, Yi, C, Xiu-Bao, Z, Zhi-Jiao, Q. Acute infectious torticollis. Neurology 1983; 33: 1344–6.
237.Fox, GN. Acute infectious torticollis in the United States. Neurology 1985; 35: 774.
238.Komandenko, NI, Grabchuk, MA, Komandenko, AN. The questions of etiology, pathogenesis, a clinic and treatment of spastic torticollis and other extrapyramidal disorders. Zh Nevropatol Psikhiatr 1985; 85: 1783–6.
239.Gollomp, SM, Fahn, S. Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry 1987; 50: 228–9.
240.Knecht, JG. Sydenham’s chorea. A case report of neurologic sequelae in the foot. J Amer Podiatry Assoc 1983; 73: 581–5.
241.Massey, EW, Allen, NB, Cole, TB. Essential blepharospasm and Sjogren’s syndrome. Am Acad Neurol 1984; PP95.
242.Jankovic, J, Patten, BM. Blepharospasm and autoimmune diseases. Movement Disorders 1987; (in press).
243.Kurlan, R, Jankovic, J, Rubin, A, Patten, B, Griggs, R, Shoulson, I. Coexistent Meige’s syndrome and myasthenia gravis. A relationship between blinking and extraocular muscle fatigue? Arch Neurol 1987; 44: 1057.
244.Nath, A, Jankovic, J, Pettigrew, LC. Movement disorders and AIDS. Neurology 1987; 37: 3741.
245.Diamond, EL, Trobe, JD, Belar, CD. Psychological aspects of essential blepharospasm. J Nerv Ment Dis 1984; 172: 749–56.
246.Wolintz, AH, Miller, CF. Stress and visual function. Mt Sinai J Med 1987; 54: 7885.
247.Rentrop, E, Straschill, M. Effect of emotional factors on the occurrence of idiopathic spasmodic torticollis. Z Psychosom Med Psychoanal 1986; 32: 4459.
248.Yonchev, V, Yonchev, A. The functional conditions of the extrapyramidal system and neuroleptic acute dystonias. Folia Medica 1984; 26: 25–8.
249.Schott, GD. Induction of involuntary movements by peripheral trauma: an analogy to causalagia. Lancet ii 1986; 712–5.
250.Schott, GD. The relationship of peripheral trauma and pain to dystonia. J Neurol Neurosurg Psychiatry 1985; 48: 698701.
251.Lesser, RP, Fahn, S. Dystonia: a disorder often misdiagnosed as a conversion reaction. Am J Psychiatry 1978; 153: 349452.
252.Batshaw, ML, Wächter, RC, Decker, AW. Munchausen’s syndrome simulating torsion dystonia. New Engl J Med 1985; 312: 14371439.
253.Lang, AE. Munchausen’s syndrome simulating torsion dystonia.? Engl J Med 1985; 313: 1088.
254.Zeman, W. Pathology of the torsion dystonias (dystonia musculorum deformans). Neurology 1970; 20: 7988.
255.Zweig, RM, Hedreen, JC, Jankel, WR, Casanova, MF, Whitehouse, PJ, Price, DL. Pathology in brainstem regions of individual with primary dystonia. Neurology 1988; 38: 702–6.
256.Hornykiewicz, O, Kish, S, Becker, L, Farley, I, Shannak, K. Brain neurotransmitters in dystonia musculorum deformans. New Engl J Med 1986; 315: 347–53.
257.Jankovic, J, Svendsen, CN. Brain neurotransmitters in dystonia. N Engl J Med 1987; 316: 278279.
258.Quattrini, A, Cinti, F, Cianci, F, Ortenzi, A, Paggi, A, Silvestri, R. Clinical and CT aspects of torsion dystonias. Riv Pat Nerv Ment 1981; 102: 181–91.
259.Friedman, JH, Chiucchini, MAJI, Tucci, JR. Idiopathic hypoparathyroidism with extensive brain calcification and persistant neurologic dysfunction. Neurology 1987; 37: 307–9.
260.Lucci, B, Zueco, R. Striopallidodentate calcifications. Report of two cases. Riv Patol Nerv Ment 1981; 102: lll.
261.Micheli, F, Pardal, MMF, Parera, IC, Giannaula, R. Spasmodic paroxysmal dystonic choreoathetosis associated with basal ganglia calcifications. Ann Neurol 1986; 20: 750.
262.Yamamoto, K, Kawazawa, S. Basal ganglion calcification in paroxysmal dystonic choreoathetosis. Ann Neurol 1987; 22: 556.
263.Caraceni, T, Broggi, G, Avanzini, G. Familial idopathic basal ganglia calcification exhibiting “dystonia musculorum deforman” features. Europ Neurol 1974; 12: 351359.
264.Saint-Hilaire, M-H, Burke, RE, Fahn, S, Bressman, SB. Delayed onset dystonia following prenatal or childhood anoxia: natural history and treatment. Neurology 1988; 38 (Suppl 1): 130.
265.Inbody, S, Jankovic, J. Hyperkinetic mutism: bilateral ballism and basal ganglia calcification. Neurology 1986; 36: 825–7.
266.Andrew, J, Fowler, C, Harrison, MJG. Hemi-dystonia due to focal basal ganglia lesion after head injury and improved by stereotaxic thalamotomy. J Neurol Neurosurg Psychiatry 1982; 45: 276.
267.Hirase, T, Kawasaki, S, Araki, S. Familial dystonia with atrophy of the putamen and caudate nuclei detected by CT scan – biochemical study of catecholamine metabolism. Rinsho Shinkeigaku 1983; 23: 585–91.
268.Mills, KLG, Scotland, TR, Wardlaw, D, Wytch, R. Rapid development of basal ganglia calcification caused by anoxia. J Neurol Neurosurg Psychiatry 1988; 51: 449–50.
269.Keane, JR, Young, JA. Blepharospasm with bilateral basal ganglia infarction. Arch Neurol 1985; 42: 1206–8.
270.Maki, Y, Akimoto, H, Enomoto, T. Injuries of basal ganglia following trauma in children. Child’s Brain 1980; 7: 113–23.
271.Pauranik, A, Verma, A, Maheshwari, MC. Reversible movement disorder in a patient with post traumatic basal ganglia haematoma. J Neurol Neurosurg Psychiatry 1987; 50: 1076–7.
272.Altrocchi, PH, Forno, LS. Spontaneous oral-facial dyskinesia: neuropathology of a case. Neurology 1983; 33: 802–5.
273.Williams, AC, Owen, C, Heath, DA. A compulsive movement disorder with cavitation of caudate nucleus. J Neurol Neurosurg Psychiatry 1988;51:447–8.
274.Daras, M, Georgakopoulos, T, Avdelidis, D. Late onset posthemiplegic dystonia in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1988; 51: 151–2.
275.De Lellis, M, Rosini, MP, Frascarelli, M, Palladini, G. Un caso dispasmo di torsione. Studio morfologico e biochimico. Acta Neurologica 1976; 31: 100103.
276.Messimy, R, Diebler, C, Metzger, J. Dystonie de torsion du membre supérieur gauche probablement consecutive a un traumatisme crânien. Neurol (Paris) 1977; 133: 199206.
277.LeWitt, PA, Martin, SD. Dystonia and hypokinesis with putaminal necrosis after methanol intoxication. Clin Neuropharmacol 1988; 11: 161–7.
278.Berkovic, SF, Karpati, G, Carpenter, S, Lang, AE. Progressive dystonia with bilateral putaminal hypodensities. Arch Neurol 1987; 44: 11841187.
279.D’Alessandro, R, Tinuper, P, Lozito, A, Sacquegna, T, Cortelli, P, Pazzaglia, P. CT scan in a case of progressive generalized dystonia with amyotrophic paraplegia. Ital J Neurol Sci 1983; 3: 335337.
280.Brett, EM, Hoare, RD, Sheehy, MP, Marsden, CD. Progressive hemidystonia due to focal basal ganglia lesions after mild head trauma. J Neurol Neurosurg Psychiatry 1981; 44: 460.
281.Traub, M, Ridley, . A Focal dystonia in association with cerebral infarction. J Neurol Neurosurg Psychiatry 1982; 45: 1073–4.
282.Demierre, B, Rondot, P. Dystonia caused by putamino-capsulo caudate vascular lesions. J Neurol Neurosurg Psychiatry 1983; 46: 404–9.
283.Russo, LS Jr.Focal dystonia and lacunar infarction of the basal ganglia. Arch Neurol 1983; 40: 61–2.
284.Grimes, JD, Hassan, MN, Quarrington, AM, D’Alton, J. Delayedonset posthemiplegic dystonia: CT demonstration of basal ganglia pathology. Neurology 1982; 32: 1033–5.
285.Fross, RD, Martin, WRW, Li, D, et al.Lesions of the putamen: their relevance to dystonia. Neurology 1987; 37: 1125–9.
286.Serby, M, Goodgold, A. Tardive dyskinesia-like disorder due to basal ganglia infarction. J Clin Psychopharmacol 1986; 6: 122.
287.Narbona, J, Obeso, JA, Tunon, T, Martinez-Lage, JM, Marsden, CD. Hemi-dystonia secondary to localised basal ganglia tumour. J Neurol Neurosurg Psychiatry 1984; 47: 704–9.
288.Franke, A, Neu, I. A case of torsion dystonia after carbon monoxide poisoning. Nervenarzt 1977; 48: 345–7.
289.Anegawa, T, Harada, K, Akiguchi, I, Kameyama, M. Two cases of posthemiplegic dystonia and contralateral striatal low density area on CT caused by inflammatory vasculitis. Rinsho Shinkeigaku 1986; 26: 180–3.
290.Eaton, JM. Hemidystonia due to subdural hematoma. Neurology 1988; 38:507.
291.Friedman, Dl, Jankovic, J, Rolak, LA. Arteriovenous malformation presenting as hemidystonia. Neurology 1986; 36: 1590–3.
292.Glatt, SL, Nausieda, PA. Posthemiplegic dystonia: radioautographic and pharmacologic analysis. Am Acad Neurol 1984; PP354.
293.Kaste, M, Iivanainen, M, Juntunen, J, Setale, A. Brain involvement in spasmodic torticollis. Acta Neurol Scand 1981; 63: 373–80.
294.Chopra, JS, Radhakrishnan, K, Sridharan, R. Meige’s syndrome: clinical, pharmacological and radiological observations. Clin Neurol Neurosurg 1981; 83: 145.
295.van Hoof, JJM, Horstink, MWI, Berger, HJC, van Spaendonck, KPM, Cools, AR. Spasmodic torticollis: the problem of pathophysiology and assessment. J Neurol 1987; 234: 322–7.
296.Obeso, JA, Martinez Vila, E, Delgado, G, Vaamonde, J, Maravi, E, Martinez Lage, JM. Delayed onset following hémiplégie migraine. Headache 1984; 24: 266–8.
297.Rasmusson, K, Fabian, RH. Posttraumatic focal dystonia. Am Acad Neurol 1984; PP170.
298.Powers, JM. Blepharospasm due to unilateral diencephalon infarction. Neurology 1985; 35: 283–4.
299.Solomon, GE, Engel, M, Hecht, HL, Rapoport, AR. Progressive dyskinesia due to internal cerebral vein thrombosis. Neurology 1982; 32: 769–72.
300.Rousseaux, M, Combelles, G, Petit, H. Bilateral internuclear ophthalmoplegia, ataxia and dystonia with post-traumatic pontine hematoma. Rev Otoneuroophtalmol 1984; 56: 5762.
301.Dietl, HW, Pulst, St-M, Engelhardt, p, Mehraein, P. Paraneoplastic brainstem encephalitis with acute dystonia and central hypoventilation. J Neurol 1982; 227: 229238.
302.Gimenez-Roldan, S, Barraquer-Bordas, LL. Torsion dystonia: historical evolution with a note on the Spanish contribution. Arch Neurobiol (Madr) 1986; 49: 99112.
303.Marsden, CD, Obeso, JA, Zarranz, JJ, Lang, AE. The anatomical basis of symptomatic hemidystonia. Brain 1985; 108: 463–83.
304.Jankovic, J. Blepharospasm with basal ganglia lesions. Arch Heurol 1986; 43: 866–7.
305.Quinn, N, Bydder, G, Leenders, N, Marsden, CD. Magnetic resonance imaging to detect deep basal ganglia lesions in hemidystonia that are missed by computerized tomography. Lancet ii 1985; 1007–8.
306.Larsen, TA, Dunn, HG, Jan, JE, Calne, DB. Dystonia and calcification of the basal ganglia. Neurology 1985; 35: 533–7.
307.Mas, J-L, Launay, M, Derouesne, C. Hemiballism and CT-documented lacunar infarct in the lenticular nucleus. J Neurol Neurosurg Psychiatry 1987; 50: 104–5.
308.Gross, M. Giant middle cerebral aneurysm presenting as hemi parkinsonism. J Neurol Neurosurg Psychiatry 1987; 50: 107584.
309.House, A, Hodges, J. Persistent denial of handicap after infarction of the right basal ganglia: a case study. J Neurol Neursurgery Psychiatry 1988; 51: 112–5.
310.Bronstein, AM, Rudge, P. Vestibular involvement in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1986; 49: 290–5.
311.Diamond, SG, Markham, CH, Baloh, RW. Ocular counterrolling abnormalities in spasmodic torticollis. Arch Neurol 1988; 45: 164–9.
312.Dawson, DM, Feudo, P, Zubick, HH, Rosenberg, R, Fowler, H. Electro-oculographic findings in Machado-Joseph disease. Neurology 1982; 32: 1272–6.
313.Day, TJ, Lefroy, RB, Mastaglia, FL. Meige’s syndrome and palatal ’ myoclonus associated with brain stem stroke. A common mechanism? J Neurol Neurosurg Psychiatry 1986; 49: 1324–5.
314.Lang, AE, Sharpe, JA. Blepharospams associated with palatal myoclonus and communicating hydrocephalus. Neurology 1984; 34: 1522.
315.Anon. Blepharospasm associated with palatal myoclonus and communicating hydrocephalus (letter). Neurology 1984; 34: 1522–4.
316.Sandyk, R, Gillman, MA. Blepharospasm associated with palatal myoclonus and communicating hydrocephalus. Neurology 1984; 34: 1522–3.
317.Jankovic, J. Blepharospasm associated with palatal myoclonus and communicating hydrocephalus. Neurology 1984; 34: 1523.
318.Scherokman, B, Husain, F, Cuetter, A, Jabbari, B, Maniglia, E. Peripheral dystonia. Arch Neurol 1986; 43: 830–2.
319.Al-Kawi, MXZ. Focal dystonia in spinal stenosis. Arch Neurol 1987;44:692–3.
320.K’omar, J, Szegwari, M. Peripheral neurologic background of writer’s cramp: type with median nerve lesion. Nervenarzt 1983; 54: 322–5.
321.Witt, TN, Jager, M. Congenital subluxation of the metacarpophalangeal joint of the thumb as the cause of writer’s syndrome. Z Orthop 1984; 122: 37–9.
322.Canale, ST, Griffin, DW, Hubbard, CN. Congenital muscular torticollis. J Bone Joint Surg 1982; 64: 810.
323.Morrison, DL, MacEwen, GD. Congenital muscular torticollis: observations regarding clinical findings, associated conditions, and results of treatment. J Ped Orthoped 1982; 2: 500–5.
324.Nemet, P, Godei, V, Baruch, E, Lazar, M. Pitfall of acquired ocular torticollis. J Ped Ophthal Strabismus 1980; 17: 310–1.
325.Sty, JR, Wells, RG, Schroeder, BA. Congenital muscular torticollis: computed tomographic observations. Am J Dis Child 1987; 141: 243–4.
326.Dyck, P. Spasmodic torticollis and neurovascular compression. J Neurosurg 1986; 64: 686687.
327.Girodias, J-B, Duhaime, M, Marton, D, Berner, M, Boisvert, J. Calcification d’un disque intervertebral: cause inhabituelle de torticolis chez l’enfant. L’Union Med du Can 1980; 109: 107880.
328.Pagni, CA, Naddeo, M, Faccani, G. Spasmodic torticollis due to neurovascular compression of the 11th nerve. J Neurosurg 1985; 63: 789–91.
329.Shima, F, Fukui, M, Matsubara, T, et al.Spasmodic torticollis caused by vascular compression of the spinal accessory root. Surg Neurol 1986; 26: 431–4.
330.Freckmann, N, Hagenah, R. Relationship between the spinal accessory nerve and the posterior root of the first cervical nerve in spasmodic torticollis and common autopsy cases. Zantralbl Neurochir 1986; 47: 134–8.
331.Rubin, SE, Wagner, RS. Ocular Torticollis. Survey Ophthalmology 1986; 30: 366–76.
332.Sarnat, HB, Morrissy, RT. Idiopathic torticollis: sternocleidomastoid myopathy and accessory neuropathy. Muele Nerve 1981; 4: 374–80.
333.Hadari, A, Azizi, E, Lernau, O, Nissan, S. Sandifer’s syndrome – a rare complication of hiatal hernia. A case report. Z Kinderchir 1984; 39: 202–3.
334.Taboas-Perez, RA, Rivera-Reyes, L. Head tilt: a revisit to an old sign of posterior fossa tumors. Assoc Med Puerto Rico Bol 1987; 76: 62–5.
335.Kiwak, KJ, Deray, MJ, Shields, WD. Torticollis in three children with, syringomyelia and spinal cord tumor. Neurology 1983; 33: 946–8.
336.Maxwell, RE. Surgical management of torticollis. Postgrad Med 1984; 75: 147–55.
337.Robb, JE, Southgate, GW. An unusual case of torticolles. J Pediat Orthop 1986; 6: 469.
338.Dubousset, J. Torticollis in children caused by congenital anomalies of the atlas. J Bone Joint Surgery 1986; 68A: 178.
339.Bagolini, B, Campos, EC, Chiesi, C. Plagiocephaly causing superi or oblique deficiency. Arch Ophthalmol 1982; 100: 1093–6.
340.Wang, FM. Plagiocephaly and torticollis. J Pediatrics 1981; 99: 164.
341.Junck, L, Gilman, S, Hichwa, RD, Young, AB, Markel, DS, Ehrenkaufer, RLE. PET studies of local cerebral glucose metabolism in idiopathic torsion dystonia. Neurology 1986; 36(Suppl 1): 182.
342.Tempel, LW, Perlmutter, JS. Abnormal cerebral blood flow response to vibrotactile stimulation in dystonics. Neurology 1988; 38(Suppl 1): 131.
343.Stoessl, AJ, Martin, WRW, Clark, C, et al.PET studies of cerebral glucose metabolism in idiopathic torticollis. Neurology 1986; 36: 653–7.
344.Perlmutter, JS, Raichle, ME. Pure hemidystonia with basal ganglion abnormalities on positron emission tomography. Ann Neurol 1984; 15: 228–33.
345.Jankel, WR, Allen, RP, Niedermeyer, E, Kaisher, MJ. Polysomnographie findings in dystonia musculorum deformans. Sleep 1983; 6: 281–5.
346.Jankel, WR, Neidermeyer, E, Graf, M, Kalsher, M. Polysomnography of torsion dystonia. Arch Neurol 1984; 41: 10811083.
347.Jankel, WR, Niedermeyer, E, Graf, M, Kalsher, MJ. Case report: Polysomnographie effects of thalamotomy of torsion dystonia. Neurosurg 1984; 14:495–8.
348.Wein, A, Golubev, V. Polygraphie analysis of sleep in dystonia musculorum deformans. Waking & Sleeping 1979; 3: 4150.
349.Narayan, TM, Ludwig, C, Sato, S. A study of multimodality evoked responses in idiopathic spasmodic torticollis. Electroencephalog Clin Neurophysiol 1986; 63: 239–41.
350.Zeitlhofer, J, Brainin, M, Reisner, TH. BAEP abnormalities in tardive dyskinesia. J Neurol 1984; 231: 266–8.
351.Golubev, VL. Facial paraspasm. Zh Nevropatol Psikhiatr 1986; 86: 504–9.
352.Jacome, DE, Risko, M. Photic induced-driven PLEDs in paroxysmal dystonic choreoathetosis. Clin Electroenceph 1984; 15: 153.
353.Quinn, NP, Marsden, CD. Dominantly inherited myoclonic dystonia with dramatic response to alcohol. Am Acad Neurol 1984; PP7.
354.Karson, CN, Burns, RS, LeWitt, PA, Foster, NL, Newman, RP. Blink rates and disorders of movement. Neurology 1984; 34: 677–8.
355.Tatton, WG, Bedingham, W, Verrier, MC, Blair, RDG. Characteristic alterations in responses to imposed wrist displacements in parkinsonian rigidity and dystonia musculorum deformans. Can J Neurol Sci 1984; 11: 281–7.
356.Rothwell, JC, Obeso, JA, Day, BL, Marsden, CD. Pathophysiology of dystonias. In: Desmedt, JE, ed. Motor Control Mechanisms in Health and Disease, Raven Press, NY, 1983; pp 851–63.
357.Fasshauer, K. Klinische und elektromyographische Verlaufsuntersuchungen beim Torticollis spasmodicus. Nervenarzt 1983;54:535–9.
358.Marsden, CD. The pathophysiology of movement disorders. Neurol Clin 1984; 2: 435–59.
359.Thompson, PD, Dick, JPR, Day, BL, et al.Electrophysiology of the corticomotoneurone pathways in patients with movement disorders. Movement Disorders 1986; 1: 113–7.
360.Stejskal, L, Tomanek, Z. Postural laterality in torticollis and torsion dystonia. J Neurol Neurosurg Psychiatry 1981; 41: 1029–34.
361.Corbin, DOC, Williams, AC, White, AC. Tardive dystonia: which way do schizophrenics twist? Lancet 1987; 1: 268–9.
362.Wolfson, LI, Sharpless, NS, Thal, LJ, Waltz, JM, Shapiro, K. Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia. Neurology 1983; 33: 369–72.
363.Tabaddor, K, Wolfson, LI, Sharpless, NS. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia. Neurology 1978; 28: 1254–8.
364.Tabaddor, K, Wolfson, LI, Sharpless, NS. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–53.
365.Barkhatova, VP, Kandel, EI, Demina, EG. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases. Neurosci Behav Physiol 1985; 15: 132–9.
366.West, KA, Edvinson, L, Nielsen, KC, et al.Concentration of acid monoamine metabolites in ventricular CSF of patients with posterior fossa tumours. In: Brock, M, Dietz, H, eds. Intracranial Pressure: Experimental and Clinical Aspects. Springer-Verlag. Berlin, 1972; pp. 331–7.
367.Curzon, G, Kantamaneni, BD, Bartlett, JR, et al.Transmitter precursors and metabolites in human ventricular cerebrospinal fluid. J Neurochem 1976; 26: 613–5.
368.Stahl, SM, Faull, KF, Barchas, JD, Berger, PA. CSF monoamine metabolites in movement disorders and normal aging. Arch Neurol 1985; 42: 166–9.
369.Busard, HLSM, Renier, WO, Gabreels, FJM, Horstink, MWJM, Rotteveel, JJ. Sporadic distal dystonia: a clinical study of seven juvenile cases. Clin Neurol Neurosurg 1983; 85: 23–9.
370.Chase, TN, Gordon, EK, Ng, LKY. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid. J Neurochem 1973; 21: 581–7.
371.Lai, S, Allen, J, Etienne, P, Sourkes, TL, Humphreys, P. Dopaminergic function in Gilles de la Tourette’s syndrome, Sydenham’s chorea and torsion dystonia. Clin Neurol Neurosurg 1976; 79: 66–9.
372.Fahn, S. Systemic therapy of dystonia. Can J Neurol Sci 1987; 14: 528–32.
373.Willemse, J, Van Nieuwenhuizen, O, Gooskens, RH, Westenberg, HGM. Treatment of non-fluctuating progressive dystonia a neu-ropharmacological approach. Neuropediatrics 1984; 15: 208–10.
374.Sunohara, N, Mukoyama, M, Mano, Y, Satoyoshi, E. Actioninduced rhythmic dystonia: an autopsy case. Neurology 1984; 34: 321–7.
375.Shimoyamada, Y, Yoshikawa, A, Kashii, H, Kihira, S, Koike, M. Hereditary progressive dystonia – an observation of the catecholamine metabolism during L-DOPA therapy in a 9-year old girl. No To Hattatsu 1986; 18: 505–9.
376.Abbott, RJ, Currie, S, Howe, JG, Sumner, DW. Cerebrospinal fluid ?-aminobutyric acid in spasmodic torticollis. Ann Neurol 1983; 13: 342.
377.Perry, TL, Hansen, S, Quinn, N, Marsden, CD. Concentration of GABA and other amino acids in CSF from torsion dystonia patients. J Neurochem 1982; 39: 1188–91.
378.Thai, LJ, Sharpless, NS, Rosenbaum, D, Davies, P, Amin, IM, Waltz, JM. Ventricular fluid somatostatin concentration decreases in childhood-onset dystonia. Neurology 1985; 35: 1742–6.
379.Cramer, H, Wolf, A, Rissler, K, Weigel, K, Osterlag, C. Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease. J Neurol 1985; 232: 219–22.
380.Cullis, PA, Townsend, L, LeWitt, P, Pomara, N, Reitz, D. Electrophoresis and immunoblot of cerebrospinal fluid proteins in spasmodic torticollis. Movement Disorders 1986; 1: 179186.
381.LeWitt, PA, Newman, RP, Miller, LP, Lovenberg, W, Eldridge, R. Treatment of dystonia with tetrahydrobiopterin (letter). N Engl J Med 1983; 308: 157–8.
382.LeWitt, PA, Miller, LP, Levine, RA, et al.Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials. Neurology 1986; 36: 760–4.
383.Smith, I, Leeming, RJ, Cavanagh, NP, Hyland, K. Neurological aspects of biopterin metabolism. Arch Dis Child 1986; 61: 1307.
384.Williams, A, Eldridge, R, Levine, R, Lovenberg, W, Paulson, G. Low CSF hydroxylase cofactor (tetrahydrobiopterin) levels in inherited dystonia. Lancet ii 1979; 410–1.
385.Williams, AC, Levine, RA, Chase, TN, Lovenberg, W, Calne, DB. CSF hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry 1980; 43: 735–8.
386.Tanaka, K, Yoneda, M, Nakijima, T, Miyatake, T, Owada, M. Dihydrobiopterin synthesis defect: an adult with diurnal fluctuation of symptoms. Neurology 1987; 37: 519–22.
387.Mehta, BC, Srinivas, HV, Taly, AB. Dystonia musculorum defor mans with hyperuricaemia study of a family. Clin Neurol Neurosurg 1982; 84: 2936.
388.Coleman, M. Effect of nicotinamide administration in a patient with an extrapyramidal movement disorder and hyperuricemia: a double-blind crossover study. Adv Neurol 1976; 14: 297302.
389.Wooten, GF, Eldridge, R, Axelrod, J, Stern, RS. Elevated plasma dopamine-beta-hydroxylase activity in an autosomal dominant torsion dystonia. N Engl J Med 1973; 288: 284–7.
390.Ziegler, MG, Lake, CR, Eldridge, R, Kopin, IJ. Plasma norepinephrine and dopamine-beta-hydroxylase in dystonia. Adv Neurol 1976; 14: 307–15.
391.Ebstein, RP, Freedman, LS, Lieberman, A, et al.A familial study on serum dopamine-beta-hydroxylase levels in torsion dystonia. Neurology 1974; 24: 684–7.
392.Menkes, JH, Wetterberg, L, Ross, SB, et al.Catecholaminergic activity in idiopathic torsion dystonia. Neurology 1987; 37: 779–83.
393.Korczyn, AD, Rabinowitz, R, Kahana, E, Streifler, M, Carasso, R, Alter, M. Dopamine-β-hydroxylase (DBH) in idiopathic torsion dystonia. J Neurol Sci 1982; 53: 91–3.
394.Friedman, H, Mendlewicz, J. Plasma dopamine-beta-hydroxylase activity in spasmodic torticollis. Neuropsychobiology 1981; 7: 238–42.
395.Korczyn, AD, Lazarovits, J, Dvilanski, A, Eshel, Y, Nathan 1.5 Hydroxytryptamine in platelets of torsion dystonia patients. Acta Neurol Scand 1985; 71: 171–3.
396.Maltese, WA, Bressman, S, Fahn, S, DeViVivo, DC. Acetylcholinesterase activity in patients with torsion dystonia. Arch Neurol 1985; 42: 154–5.
397.Pratty, JS, Ananth, J, O’Brien, JE. Relationship between dystonia and serum calcium levels. J Clin Psychiat 1986; 47: 418–9.
398.Borisova, TV. Exchange of microelements in patients with hereditary extrapyramidal diseases. Zh Nevropatol Psikhiatr 1978; 78: 217–21.
399.Gannushkina, IV, Zhirnova, JG, Toropowa, NG, Toporkina, TD, Markova, ED. Quantitative evaluation of the T- and B- systems of immunity in various hereditary diseases of the nervous system. Zh Nevropatol Psikhiatr 1981; 81: 1009–13.
400.Moore, AP, Behan, PO, Behan, WMH. Lymphocyte subset abnormalities in patients with spasmodic torticollis. Acta Neurol Scand 1986; 74: 371–8.
401.Korein, J, Willoughby, E, Pollack, MS, Levidow, L, Dupont, B. Human leucocyte antigen in torticollis and other idiopathic dystonic symptoms. Ann Neurol 1981; 10: 573–5.
402.Mosunova, TG. The change of catecholamines in extrapyramidal disorders in children. Zh Nevropatol Psikhiatr 1977; 77: 1466–9.
403.Iwanowa-Smolenskja, JA, Barchatowa, WP. Characteristics of central neurotransmitter metabolism in hereditary extrapyramidal disorders. Neurol Neurochir Pol 1981: 15: 377–80.
404.Dadali, EL. Catecholamine excretion in various forms and at various stages of deforming myodystonia. Sov Med 1980; 41–5.
405.Iadgarov, IS. Circadian rhythm of catecholamine excretion: effect of L-DOPA in various diseases of the nervous system. Zh Nevropatol Psikhiatr 1983; 83: 1792–6.
406.Mel’nichuk, PV, Khokhlov, AP, Khailova, IM. Pathogenesis of hyperkinesias in children. Neurosci Behav Physiol 1984; 14: 241–5.
407.Breakefield, XO, Braverman, M, Riker, DK, Giller, EL Jr. Catechol-O-methyltransferase activity in cultured human skin fibroblasts from controls and patients with dystonia musculorum deformans. J Neurosci Res 1981; 6: 349360.
408.Edelstein, SB, Costa, MRC, Castiglione, CM, Breakfield, XO. Monoamine oxidase activity in fibroblasts from control individuals and patients with inherited neurologic disease. In: Usdin, E, Kopin, IJ, Barchas, J eds. Catecholamines: Basic and Clinical Frontiers. Pergamon Press, New York 1979; pp 210–12.
409.Maltese, WA, De Vivo, DC. Cholesterol and phospholipids in cultured skin fibroblasts from patients with dystonia. Ann Neurol 1984; 16: 250–2.
410.Thomas, RA, Gordon, AS, Diamond, I. Phosphoprotein phosphatase activity in normal and dystonic human fibroblast plasma membranes (41082). Proc Soc Exper Biol Med 1981; 166: 405–12.
411.Korein, J. Iris pigmentation (melanin) in segmental dystonic syndromes including torticollis. Trans Amer Neurol Assoc 1980; 105: 361–4.
412.Korein, J. Iris pigmentation (melanin) in idiopathic dystonic syndromes including torticollis. Ann Neurol 1981; 10: 53–5.
413.Korein, J. Reply to the authors. Ann Neurol 1982; 12: 586.
414.Lang, AE, Ellis, C, Kingon, H, Marsden, CD. Iris pigmentation in idiopathic dystonia. Ann Neurol 1982; 12: 585–6.
415.Nutt, JG, Carter, J, DeGarmo, P, Hammerstad, JP. Meige syndrome and thyroid dysfunction. Neurology 1984; 34 (Suppl 1): 222.
416.Lang, AE. Familial Meige syndrome and thyroid dysfunction. Neurology 1985; 35: 138.
417.Mehta, AB, Marsden, CD. Latent idiopathic torsion dystonia provoked by thyrotoxicosis. J Neurol Neurosurg Psychiatry 1981; 44: 93–4.
418.Anon. The management of dystonias. Lancet 1985; 2: 321322.
419.Poewe, WH, Lees, AJ. The pharmacology of foot dystonia in Parkinsonism. Clin Neuropharmacol 1987; 10: 4756.
420.Rondot, P, Ziegler, M. Dystonia-L-Dopa reponsive or juvenile Parkinsonism? J Neural Transmir 1983; (Suppl 19): 27381.
421.Burns, RS, LeWitt, PA, Eben, MH, Pakkenberg, H, Kopin, IJ. The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP. New Engl J Med 1985; 312: 1418–21.
422.Klawans, HL, Paleologos, N. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clin Neuropharm 1986; 9: 298302.
423.LeWitt, PA, Burns, RS, Newman, RP. Dystonia in untreated Parkinsonism. Clin Neuropharmacol 1986; 9: 293–7.
424.Burke, RE, Fahn, S. Double-blind evaluation of trihexyphenidyl in dystonia. Adv Neurol 1983; 37: 189192.
425.Fahn, S. High dosage anticholinergic therapy in dystonia. Neurology 1983; 33: 1255–61.
426.Burke, RE, Fahn, S, Marsden, CD. Torsion dystonia: A double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986; 36: 160–4.
427.Marsden, CD, Marion, M-H, Quinn, N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984; 47: 1166–73.
428.Pakkenberg, H, Pedersen, B. Medical Treatment of dystonia. In: Casey, DE, Chase, TN, Christensen, AV, Gerlach, J, eds. Dyskinesia – Research and Treatment, Springer-Verlag, Berlin 1985; pp. 111–7.
429.Boyson, SJ. Bethanechol for anticholinergic side effects. Ann Neurol 1988; 23: 422–3.
430.Lang, AE. High dose anticholinergic therapy in adult dystonia. Can J Neurol Sci 1986; 13: 42–6.
431.Lang, AE, Sheehy, MP, Marsden, D. Anticholinergics in adult-onset dystonia. Can J Neurol Sci 1982; 9: 313–8.
432.Lang, AE, Sheehy, MP, Marsden, CD. Acute anticholinergic action in focal dystonia. Adv Neurol 1983; 37: 193–9.
433.Burke, RE, Fahn, S. Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients. Ann Neurol 1985; 18: 3540.
434.Burke, RE, Fahn, S. Serum trihexyphenidyl levels in the treatment of torsion dystonia. Neurology 1985; 35: 1066–9.
435.Campanella, G, Roy, M, Barbeau, A. Drugs affecting movement disorders. Ann Rev Pharmacol Toxicol 1987; 27: 113–36.
436.Castaigne, P, Rondot, P, Ribadeau Dums, JL, Said, G.Affection extrapyramidale évoluant chez deuz freres: effets remarquables du traitement par la L-dopa. Rev Neurol 1971; 124: 162–6.
437.Sabouraud, O, Allant, H, Pinel, J-F, Menault, F. Familial dystonia transformed by bromocriptine. Nouv Presse Med 1978; 7: 3370.
438.Micheli, F, Pardal, MF, de Arbelaiz, R, Lehkuniec, E, Giannaula, R. Paroxysmal dystonia responsive to anticholinergic drugs. Clin Neuropharmacol 1987; 10: 365–9.
439.Lang, AE. Dopamine agonists in the treatment of dystonia. Clin Neuropharmacol 1985; 8: 3857.
440.Eldridge, R, Kanter, W, Coerber, T. Levodopa in dystonia. Lancet 2 1973; 1027–8.
441.Allen, N, Knopp, W. Hereditary parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication. Adv Neurol 1976; 14: 201–13.
442.Balottin, U, Lanzi, G, Zambrino, CA. A case of dystonia musculorum deformans susceptible to the L-Dopa therapy. Riv Neurobiol 1981; 27: 584–90.
443.Bondarenko, ES, Malyshev, lui. Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkinesis in infantile cerebral palsy. Zh Nevropatol Psikhiatr 1985; 85: 1471–5.
444.Casey, DE. Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology 1980; 30: 690–5.
445.Garcia-Albea, E, Munoz, D, Mateos, F, Martinez, P, Golzueta, G. Sindrome de Brueghel. Aportacion de un caso. Rev Clin Exp 1979; 153:6970.
446.Garg, BP. Dystonia musculorum deformans. Implications of therapeutic response to levodopa and carbamazepine. Arch Neurol 1982; 39: 376–7.
447.Ignatowicz, R, Michalowicz, R, Kmiec, T. Problemy etiopatogene-tyczne i kliniczne dystonii torsyjnej u dzieci. Wiadomosci Lekarske 1983; 36: 11971200.
448.Katsukawa, K, Hosokawa, K, Sano, Y, Otsuka, R. Remarkable effect of haloperidol in torsion dystonia: a case report. Rinsho Shinkeigaku 1976; 16: 351–6.
449.Marsden, CD, Lang, AE, Sheehy, MP. Pharmacology of cranial dystonia. Neurology 1983; 33: 1100–1.
450.Muenter, MD, Gomez, MR, Gordon, H, Sharpless, NS. L-Dopa-responsive dystonia musculorum deformans with on-off effect. Neurology 1982; 32: Al12.
451.Patti, F, Marano, P, Nicoletti, F, Giammona, G, Nicoletti, Fr. Generalized and focal dystonic symptoms: possible therapy with salmon calcitonin. Eur Neurol 1985; 24: 386–91.
452.Richards, CL, Bedard, PJ, Fortin, G, Malouin, F. Quantitative evaluation of the effects of L-DOPA in torsion dystonia: a case report. Neurology 1983; 33: 1083–7.
453.Schenk, E, Kruschke, U. Familiare progressive Dystonie mit Tagesschwankungen. Erfolgreiche Behandlung mit L-DOPA. Klin Wochenschr 1975; 53: 779–80.
454.Stahl, SM, Davis, KL, Berger, PA. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias. J Clin Psychopharmac 1982; 2: 321–8.
455.Stahl, SM, Yesavage, JA, Berger, PA. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia. J Clin Psychiatry 1982b; 43: 445.
456.Stahl, SM, Berger, PA, Newman, RP, LeWitt, P. Reply from the authors Neurology 1984a; 34: 135.
457.Still, CN, Herberg, K-P. Long-term levodopa therapy for torsion dystonia. Southern Med J 1976; 69: 564.
458.Tolosa, ES, Chi-Wan, L. Meige disease: striatal dopaminergic preponderance. Neurology 1979; 29: 1126–30.
459.Winkelmann, W. Long-term treatment with L-DOPA in a case of torsion dystonia. J Neurol 1975; 208: 319–23.
460.Bassi, S, Ferrarese, C, Frattola, L, Sbacchi, M, Trabucchi, M. Lisuride in generalised dystonia and spasmodic torticollis. Lancet 2 1982; 514.
461.Bosio, A. Bassi, S, Govoni, S, et al.Lisuride in extrapyramidal disorders: A possible mechanism of action. Adv Neurol 1984; 40: 523–6.
462.Esperanca, P, Castro-Caldas, A. Improvement of Meige syndrome with lisuride. Acta Med Port 1985; 6: 187–9.
463.Frattola, L, Albizzati, MG, Bassi, S, Ferrarese, C, Trabucchi, M. “On-off” phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment. Acta Neurol Scand 1982;66:227–36.
464.Leiguarda, RC, Pardal, MF, Micheli, F. Reply from the authors. Neurology 1984; 34: 136.
465.Micheli, F, Pardal, MMF. Responses to lisuride in Meige’s disease and chorea. Neurology 1986; 36: 445.
466.Micheli, F, Pardal, MMF, Leiguarda, RC. Beneficial effects of lisuride in Meige disease. Neurology 1982; 32: 432–4.
467.Obeso, JA, Luquin, MR. Bromocriptine and lisuride in dystonias. Neurology 1984; 34: 135.
468.Nutt, JG, Hammerstad, J, Carter, J, deGarmo, P. Lisuride treatment of focal dystonias. Neurology 1985; 35: 1242–3.
469.Quinn, NP, Lang, AE, Sheehy, MP, Marsden, CD. Lisuride in dystonia. Neurology 1985; 35: 766–9.
470.Frattola, L, Albizzati, MG, Bassi, S, Spano, PF, Trabucchi, M. Treatment of dyskinetic and dystonic disorders with CF 25–397: clinical and pharmacological aspects. Adv Biochem Psychopharmacol 1980; 23: 381–6.
471.Gautier, JC, Awada, A. Dystonia musculorum deformans. Effet favorable de la bromocriptine. Rev Neurol (Paris) 1983; 139: 449–50.
472.Girotti, F, Scigliano, G, Nardocci, N, et al.Idiopathic dystonia: neuropharmacological study. J Neurol 1982; 227: 239–47.
473.Newman, RP, LeWitt, PA, Shults, C, et al.Dystonia: Treatment with bromocriptine. Clin Neuropharmacol 1985; 8: 328–33.
474.Stahl, SM, Berger, PA. Bromocriptine in dystonia. Lancet 2: 1981; 745.
475.Stahl, SM, Berger, PA. Bromocriptine, physostigmine and neurotransmitter mechanisms in the dystonias. Neurology 1982; 32: 889–90.
476.Greene, P, Fahn, S. Tardive complications in patients with idiopathic dystonia treated with dopamine blocking agents. Neurology 1988; 38(Suppl 1): 131.
477.Couch, JR. Dystonia and tremor in spasmodic torticollis. Adv Neurol 1976; 14: 245–58.
478.Gilbert, GJ. The medical treatment of spasmodic torticollis. Arch Neurol 1972; 27: 503–6.
479.Gollomp, SM, Fahn, S, Burke, RE, Reches, A, Ilson, J. Therapeutic trials in Meige syndrome. Adv Neurol 1983; 37: 207–10.
480.Nakajima, Y, Kondo, T, Narabayashi, H. Long-term evaluation of tiapride in patients with various forms of dyskinesias. No To Shinkei 1985; 37: 1013–9.
481.Ransmayr, G, Kleedorfer, B, Dierckx, RA, Poewe, W, Kemmler, GW, Gerstenbrand, F. Pharmacological study in Meige’s syndrome with predominant blepharospasm. Clin Neuropharmacol 1988; 11: 681–76.
482.Sechi, GP, deMontis, G, Rosati, G. Relationship between Meige syndrome and alpha-methyldopa-induced parkinsonism. Neurology 1985; 35: 1668–9.
483.Burke, RE, Fahn, S, Jankovic, J, et al.Tardive dystonia: late-onset and persistant dystonia caused by antipsychotic drugs. Neurology 1982; 32: 1335–46.
484.Coats, ME. Meige’s disease and a positive treatment response with deanol. Milit Med 1985; 150: 152–3.
485.Hughes, EC, Brackmann, DE, Weinstein, RC. Seventh nerve spasm: effect of modification of cholinergic balance. Otolaryngol Head Neck Surg 1980; 88: 491–9.
486.Skarf, B, Sharpe, JA. Choline for blepharospasm. N Engl J Med 1987; 305: 957–8.
487.Lees, A. Hemidystonia relieved by nicotine. Lancet 2 1984; 871
488.Duvoisin, RC. Meige syndrome: relief on high-dose anticholinergic therapy. Clin Neuropharmacol 1983; 6: 63–6.
489.Fisher, CM. Letter to the Editor. Neurology 1983; 33: 1101.
490.Hashimoto, T, Shindo, M, Yanagisawa, N. Treatment of dystonia with high-dosage trihexyphenidyl. Clin Neurol 1984; 24: 769–77.
491.Jabbari, B, Scherokman, BJ, Gunderson, CH, Miller, JA. Effectiveness of high doses of trihexyphenidyl in movement disorders: a preliminary report. Am Acad Neurol 1984; PP14.
492.H’ipola, D, Mateo, D, Gim’enez-Rold’an, S. Meige’s syndrome: acute and chronic responses to clonazepan and anticholinergics. Eur Neurol 1984; 23:474–8.
493.Nutt, JG, Hammerstad, JP, Carter, JH, deGarmo, P. Meige syndrome: treatment with trihexyphenidyl Adv Neurol 1983; 37: 201–5.
494.Nutt, JG, Hammerstad, JP, deGarmo, P, Carter, J. Cranial dystonia: double-blind crossover study of anticholinergics. Neurology 1984a; 34: 215–7.
495.Ravits, J, Hallett, M, Baker, M, Wilkins, D. Primary writing tremor and writer’s cramp response to anticholinergics. Neurology 1985; 35: 1387–91.
496.Tanner, CM, Glantz, RH, Klawans, HL. Meige disease; acute and chronic cholinergic effects. Neurology 1982; 32: 783–5.
497.Scherokman, B, Jabbari, B, Gunderson, CH, Miller, JM, Rappaport, HL. Trihexyphenidyl and torticollis. Neurology 1986; 36: 1626.
498.Tanner, CM, Glantz, RH, Klawans, HL. Reply from the authors. Neurology 1983; 33: 1101.
499.Wolf, ME, Koller, WC. Tardive dystonia: treatment with trihexyphenidyl. J Clin Psychopharmacol 1985; 5: 247–8.
500.Brantley, PJ, Carnrike, CL Jr, Faulstich, ME, Barkemeyer, CA. Blepharospasm: a case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback. Biofeedback Self Regul 1985; 10: 173–80.
501.Koller, WC, Biary, N.Lithium ineffective in dystonia. Ann Neurol 1983; 13: 579–80.
502.Lippmann, S, Kareus, J. Lithium for spasmodic torticollis. Am J Psychiatry 1983; 140: 946.
503.Marti-Masso, JF, Obeso, JA, Carrera, N, Astudillo, W, Martinez Lage, JM. Lithim therapy in torsion dystonia. Ann Neurol 1982; 11: 106–7.
504.Quinn, N, Marsden, CD. Lithium for painful dystonia in Parkinson’s disease. Lancet 2 1986; 1377.
505.Yung, CY. A review of clinical trials with lithium in neurology. Pharmacol Biochem Behav 1984; 21(Suppl 1): 5764.
506.Lang, AE, Marsden, CD. Alpha-methyl-paratyrosine and tetra-benazine in movement disorders. Clin Neuropharmacol 1982; 5: 375–87.
507.Asher, SW, Aminoff, MJ. Tetrabenazine and movement disorders. Neurology 1981; 31: 1051–4.
508.Jankovic, J. Treatment of hyperkinetic disorders with tetra-benazine: a double-blind crossover study. Ann Neurol 1982; 11: 41–7.
509.Jankovic, J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Adv Neurol 1983; 37: 277–89,.
510.Jankovic, J, Orman, J. Tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias. Neurology 1988; 38: 391–4.
511.Schumm, F, Dichgans, J, Zeller, E. Spontaneous oral dyskinesia. Successful treatment with tetrabenazine. Arch Psychiatr Nervenkr 1981; 230: 315–23.
512.Korein, J, Lieberman, A, Kupersmith, M, Levidow, W. Effect of L-glutamine and isoniazid on torticollis and segmental dystonia. Ann Neurol 1981; 10: 247–50.
513.Ziegler, DK. Prolonged relief of dystonic movements with diazepam. Neurology 1981; 31: 1457–8.
514.Lai, S, Young, SN, Kiely, ME, Hoyte, K, Baxter, DW, Sourkes, TL. Effect of L-tryptophan on spasmodic torticollis. Can J Neurol Sci 1981; 8: 305.
515.Meinck, HM, Conrad, B. Neuropharmacological investigations in the stiff-man syndrome. J Neurol 1986; 233: 340–7.
516.ten Houten, R, Lakke, PWF, de Jong, P, van Weerden, TW, van den Burg, W, Wesseling, H. Spasmodic torticollis: treatment with Tizanidine. Acta Neurol Scand 1984; 70: 373–6.
517.Baumann, L, Baumann, J. Betrachtungen zu einem Fall von Torsion Dystonie. Acta Neurol Scand 1963; 39: S14: 221225.
518.De Andrade, LA, Bertolucci, PM. Treatment of Meige disease with a GABA receptor agonist. Arq Neuropsiquiatr 1985; 43: 260–6.
519.Sandyk, R, Gillman, MA. Baclofen in hemifacial spasm. Intern J Neurosci 1987; 33: 261–4.
520.Rosse, RB, Allen, A, Lux, WE. Baclofen treatment in a patient with tardive dystonia. J Clin Psychiatry 1986; 47: 474–5.
521.Auff, E, Holzner, F, Wessely, P. Further therapeutic possibilities with valproic acid (Convulex). Wien Med Wochenschr 1985; 135:421–3.
522.Snoek, JW, Van Weerden, TW, Teelken, AW, Van Den Burg, W, Flakke, JPW. Meige syndrome: double-blind crossover study of sodium valproate. J Neurol Neurosurg Psychiatry 1987; 50: 1522–5.
523.Sandyk, R. Beneficial effect of sodium valproate and baclofen in spasmodic torticollis. S Afr Med J 1984; 65: 62–3.
524.Sandyk, R. Blepharospasm – successful treatment with baclofen and sodium valproate. A case report. S Afr Med J 1983; 64: 955–6.
525.Sandyk, R. Treatment of writer’s cramp with sodium valproate and baclofen. S Afr Med J 1983; 63: 702–3.
526.Brennan, MJW, Ruff, P, Sandyk, R. Efficacy of a combination of sodium valproate and baclofen in Meige’s disease (idiopathic orofacial dystonia). Br Med J 1982; 285: 853.
527.Carella, F, Girotti, F, Scigliano, G, Caraceni, T, Joder-Ohlenbusch, AM, Schechter, PJ. Double-blind study of oral gamma-vinyl GABA in the treatment of dystonia. Neurology 1986; 36: 98100.
528.Stahl, SM, Thornton, JE, Simpson, ML, Berger, PA. Gamma-vinyl-GABA in tardive dyskinesia and other movement disorders. Am Acad Neurol 1984; PP40.
529.Stahl, SM, Thornton, JE, Simpson, ML, Berger, PA, Napoliello, MJ. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders. Biol Psychiatry 1985; 20: 888–93.
530.Mondrup, K, Dupont, E, Braendgaard, H. Progabide in the treatment of hyperkinetic extrapyramidal movement disorders. Acta Neurol Scand 1985; 72: 341–3.
531.Koller, WC, Rubino, R, Gupta, S. Pharmacologie probe with progabide of GABA mechanisms in essential tremor. Arch Neurol 1987; 44: 905–6.
532.Nishikawa, T, Tanaka, M, Tsuda, A, Koga, 1, Uchida Y Clonidine therapy for tardive dyskinesia and related syndromes. Clin Neuropharmacol 1984; 7: 239–45.
533.Bailie, GR, Nelson, MV, Kranzelok, EP, Lesar, T. Unusual treatment response of a severe dystonia to diphenhydramine. Ann Emerg Med 1987; 16: 705–8.
534.Sandyk, R, Snider, SR, Consroe, P, Elias, SM. Cannabidiol in dystonic movement disorders. Psychiatry Res 1986; 18: 291.
535.Consroe, P, Sandyk, R, Snider, S. Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 1986; 30: 277–82.
536.Biary, N, Koller, W. Reply from the authors. Neurology 1986; 36: 303.
537.Biary, N, Koller, W. Effect of alcohol on dystonia. Neurology 1985; 35: 239–40.
538.Gillman, MA. Alcohol improves dystonia: opioid system involvement. Neurology 1986; 36: 303.
539.Gillman, MA. Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system: a review of the evidence. Life Sci. 1986; 39: 1209–21.
540.Gillman, MA, Sandyk, R. Nitrous oxide ameliorates spasmodic torticollis. Eur Neurol 1985; 24: 292–3.
541.Krishnan, KR. Treatment of spasmodic torticollis with ethyl chloride. J Clin Psychopharmacol 1982; 2: 286.
542.Sandyk, R. Writer’s cramp and the endogenous opioid system. Clin Neuropharmacol 1986; 9: 9899.
543.Barrow, N, Childs, A. An anti-tardive dyskinesia effect of verapamil. Am J Psychiatry 1986; 143: 1485.
544.Ross, JL, MacKenzie, TB, Hanson, DR, Charles, CR. Diltiazem for tardive dyskinesia. Lancet 2 1987; 268.
545.Falk, WE, Wojick, JD, Gelenberg, AJ. Diltiazem for tardive dyskinesia and tardive dystonia. Lancet 1988; 2: 824–5.
546.Bouchier-Hayes, T. Chlormezanone in low back pain and wry neck – an “analgesic sparing” effect. Br J Clin Prac 1984; 38: 259262.
547.Special Issue Excitatory amino acids in the brain – focus on NMDA receptors. Trends Neurosci 1987; 10: 263345.
548.Olney, JW, Price, MT, Labruyere, J, et al.Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol 1987; 142: 319–20.
549.Jayne, D, Lees, AJ, Stern, GM. Remission in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1984; 47: 1236–7.
550.Lowenstein, DH, Aminoff, MJ. The clinical course of spasmodic torticollis. Neurology 1988; 38: 530–2.
551.Friedman, A, Fahn, S. Spontaneous remissions in spasmodic torticollis. Neurology 1986; 36: 398400.
552.Brin, M, Fahn, S, Moskowitz, CB, et al.Localized injections of botulinum toxin for the treatment of focal dystonia. Adv Neurol 1988; 50: 599608.
553.Frueh, BR, Felt, DP, Wojno, TH, Musch, DC. Treatment of blepharospasm with botulinum toxin. Arch Ophthalmol 1984; 102: 1464–8.
554.Carruthers, J, Stubbs, HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 1987; 14: 42–5.
555.Mauriello, JA Jr, Coniaris, H. Use of botulinum in the treatment of 100 patients with blepharospasm. NJ Med 1987; 84: 43–4.
556.Mauriello, JA. Blepharospasm, Meige syndrome and hemifacial spasm: treatment with botulinum toxin. Neurology 1985; 35: 14991500.
557.Tsui, JKC, Stoessl, AJ, Eisen, A, Calne, S, Calne, DB. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2 1986; 245–7.
558.Tsui, JK, Eastmann, E, Mak, E, Calne, S, Calne, DB. Botulinum toxin in writer’s cramp: a pilot study. Ann Neurol 1987; 22: 147.
559.Cremonesi, E, Murata, KN. Infiltration of a neuromuscular relaxant in diagnosis and treatment of torticollis. Anesth Analg 1986; 65: 1077–8.
560.Dieckmann, G, Veras, G. Bipolar spinal cord stimulation for spasmodic torticollis. Appi Neurophysiol 1985; 48: 339346.
561.Waltz, JM, Davis, JA. Cervical cord stimulation in the treatment of athetosis and dystonia. Adv Neurol 1983; 37: 225.
562.Fahn, S. Lack of benefit from cervical cord stimulation for dystonia. New Engl J Med 1985; 313: 1229.
563.Sold-Darseff, J, Leydhecker, W. Acupuncture for pain in the cranial region and for blepharospasm without organic cause. Klin Monatsbl Augenheilkd 1986; 189: 167–9.
564.Lee, EH, Kang, YK, Bose, K. Surgical correction of muscular torti-collis in the older child. J Pediat Orthop 1986; 6: 585–9.
565.Zervas, NT. Long-term review of dentatectomy in dystonia musculorum deformans and cerebral palsy. Acta Neurochirurgica 1977; S24: 4951.
566.Cooper, IS. Dystonia: Surgical approaches to treatment and physiologic implications. In: Yahr, MD, ed. The Basic Ganglia, Raven Press, NY 1976; pp 369383.
567.Kandel, EI. Stereotaxic method of treating extrapyramidal spastic torticollis. Zh Vopr Neirokhir 1984; 6: 2834.
568.Vasin, NY, Medzhidov, MR, Shabalov, VA. Stereotaxic destruction of the interstitial nucleus of cajal in torticollis spastica. Zh Vopr Neirokhir 1985; 4: 37.
569.Andrew, J, Fowler, CJ, Harrison, MJG. Stereotaxic thalamotomy in 55 cases of dystonia. Brain 1983; 106: 9811000.
570.Starikov, AS. Effect of destruction of the ventrolateral nucleus of the thalamus on the motor analyzer. Zh Vopr Neirokhir 1981; 5: 4551.
571.Namba, S, Wani, T, Masaoka, T, Nakamura, S, Nishimoto, A. Long-term follow-up study of spasmodic torticollis. No Shinkei (Brain & Nerve) 1986; 38: 121–8.
572.Jorgenson, C, Porphyris, H. Idiopathic spasmodic torticollis. J. Neurosurg Nursing 1985; 17: 169–74.
573.Van Waveren LEAK. Cause and treatment of spasmodic torticollis. Acta Neurochir 1982; 61: 127–37.
574.Ortiz, A. Neuropharmacological profile of Meige’s disease: overview and a case report. Clin Neuropharmacol 1983; 6: 297304.
575.Husain, A, Chapel, J, Malek-Ahmadl, P. Methylphenidate, neuroleptics and dyskinesia-dystonia. Can J Psychiatry 1980; 25: 254–8.
576.Dahiya, U, Noronha, P. Drug-induced acute dystonic reactions in children. Alternatives to diphenhydramine therapy. Postgrad Med 1984; 75: 286290.
577.Cohen, GH, Casta, A, Sapire, DW, Talabi, A. Decorticate posture following “cardiac cocktail”. Ped Cardiol 1982; 2: 251253.
578.Prusi’nski, A, R’o’zniecki, J, Durko, A, Gluszcz-Zieli’nska, A, Kozubski, W, Swatko, A. Acute dystonic reactions after administration of neuroleptics and other drugs. Wien Lek 1985; 38: 347–51.
579.Anon. Acute dystonia with fatal outcome. A possible adverse drug reaction in the simultaneous administration of chlorpromazine and metoclopramide. Ugeskr Laeger 1986; 148: 2357–8.
580.Stallworth, HF. Acute dystonia secondary to illicit phenothiazine usage: a report of two cases. J Kentucky Med Assoc 1981; 79: 83–4.
581.Lew, T-L, Tollefson, G. Chlorpromazine-induced neuroleptic malignant syndrome and its responses to diazepam. Biol Psychiatry 1983; 18: 1441–5.
582.Wood, GM, Waters, AK. Prolonged dystonic reaction to chlorpromazine in myxoedema coma. Postgrad Med J 1980; 56: 192–3.
583.Ayers, JL, Dawson, KP. Acute dystonic reactions in childhood to drugs. NZ Med J 1980; 92: 464465.
584.Korczyn, AD, Goldberg, GJ. Intravenous diazepam in drug-induced dystonic reactions. Br J Psychiatry 1972; 121: 75–7.
585.Town, IG. Haloperidol: neuroleptic malignant syndrome. New Zealand Med J 1982; 95: 199.
586.Gross, ML. Acute dystonia as idiosyncratic reaction to haloperidol. Lancet 2 1980; 479–80.
587.Logan, FA, Herrington, RN, Mackie, MMS, Rubin, PC. Pimozide: adverse reaction and prolonged half-life. Brit J Psychiatry 1982; 140: 433–4.
588.Khanderia, U. Recurrent dystonic reactions induced by thiethylperazine. Drug Intell Clin Pharm 1985; 19: 550–1.
589.Vlachos, P. Dystonic reactions following thiethylperazine in children. Toxicol Letters 1982; 13: 183–4.
590.Darwish, H, Grant, R, Haslam, R, Roth, S. Promethazine-induced acute dystonic reactions. Am J Dis Child 1980; 134: 990991.
591.Shannon, M. Paroxysms, obtundation in a healthy toddler. Hospital Practice 1986; 21: 159–60.
592.Dick, DJ, Saunders, M. Persistent involuntary movements after treatment with flupenthixol. Br Med J 1981; 282: 1756.
593.Casteels-Van Daele, M, Dobosz-Cyklis, R, Van de Casseye, W, Verbeeck, P, Wijndaele, L. Refusal of further cancer chemotherapy due to antiemetic drug. Lancet 1 1984; 57.
594.Grimes, JD, Hassan, MN, Preston, DN. Adverse neurologic effects of metoclopramide. CMA Journal 1982; 126: 23–5.
595.Gupte, S. Dystonic reactions following metoclopramide therapy. Indian J Pediat 1982; 50: 291–2.
596.Cowan, AN. Acute dystonic reaction to Maxolon (metoclopramide). Med J Aust 1982; 2: 215.
597.Aasen, J, Slaastad, RA. Akutt dystoni forarsaket av metoklopramid (Primperan). Tidsskr Nor Laegeforen 1982; 102: 916–7.
598.Casteels-Van Daele, M. Metoclopramide poisoning in children. Arch Dis Childhood 1981; 56: 405–7.
599.Wandless, I, Evans, JG, Jackson, M. Fever associated with metoclopramide-induced dystonia. Lancet 1 1980; 1255–6.
600.Low, LCK, Goel, KM. Metoclopramide poisoning in children. Arch Dis Child 1980; 55: 310–2.
601.Debontridder, O. Dystonic reactions after domperidone. Lancet 2 1980; 1259.
602.Madej, TH. Domperidone – an acute dystonic reaction. Anaesthesia 1985; 40: 202.
603.Shafrir, Y, Levy, Y, Steinherz, R. Acute dystonic reaction due to domperidone in an infant. Harefuah 1986; 110: 237–8.
604.Rose, TE, Averbuch, SD. Acute dystonic reaction due to benzquinamide. Ann Intern Med 1975; 83: 231–2.
605.Yassa, R, Nair, V, Dimitry, R. Prevalence of tardive dystonia. Acta Psychiatr Scand 1986; 73: 629–33.
606.Gospe, SM Jr, Jankovic, J. Drug-induced dystonia in neuronal ceroid-lipofuscinosis. Pediatr Neurol 1986; 2: 236–7.
607.Burke, RE, Reches, A, Traub, MM, Ilson, J, Swash, M, Fahn, S. Tetrabenazine induces acute dystonic reaction. Ann Neurol 1985; 7: 200–2.
608.Burke, RE, Fahn, S, Mayeux, R, Weinberg, H, Louis, K, Willner, JH. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology 1981; 31: 1022–6.
609.Sandyk, R, Gillman, MA. Nomifensine exacerbates orofacial dyskinesia in hypothyroidism. Neurology 1985; 35: 282.
610.Finder, E, Lin, K, Ananth, J. Dystonic reaction to amitriptyline. Am J Psychiatry 1982; 139: 1220.
611.Kramer, MS, Marcus, DJ, DiFerdinando, J, Dewey, D. Atypical acute dystonia associated with tradozone treatment. J Clin Psychopharmacol 1986; 6: 117–8.
612.Gardos, G. Undiagnosed dystonic reaction secondary to amoxapine. Psychosomatics 1984; 25: 68–9.
613.Steele, TE. Adverse reactions suggesting amoxaptne-induced dopamine blockade. Am J Psychiatry 1982; 139: 1500–1.
614.Hunt-Fugata, AK, Zander, J, Lesar, TS. Adverse reactions due to dopamine blockade by amoxapine. A case report and review of the literature. Pharmacotherapy 1984; 4: 35–9.
615.Jacome, D. Carbamazepine-induced dystonia. JAMA 1979; 241: 2263.
616.McMahon, T. Dyskinesia associated with amoxapine withdrawal and use of carbamazepine and antihistamines. Psychosomatics 1986; 27: 145.
617.Martin’on, JM, Docampo, G, Martin’on, JA, Viso, JA, Pena, J. Distonia por carbamacepina. An Esp Pediat 1980; 13: 789–92.
618.Bradbury, AJ, Bentick, B, Todd, PJ. Dystonia associated with car bamazepine toxicity. Postgrad Med J 1982; 58: 525526.
619.Reynolds, EH, Trimble, MR. Adverse neuropsychiatrie effects of anticonvulsant drugs. Drugs 1985; 29: 570–81.
620.Lazaro, RP. Involuntary movements induced by anticonvulsant drugs. Mt Sinai J Med (NY) 1982; 49: 274–81.
621.Choonara, IA, Rosenbloom, L. Focal dystonic reaction due to Phenytoin. Dev Med Child Neurol 1984; 26: 677680.
622.Corey, A, Koller, W. Phenytoin-induced dystonia. Ann Neurol 1983; 14: 9293.
623.Gladhuc, EG, Devivo, DC, Volpe, JJ. Phenytoin induced dystonia and. choreoathetosis in two retarded epileptic children. Neurol 1976; 26: 498498.
624.Francis, DA. Benzodiazepines and spasmodic torticollis. Arch Neurol 1983; 40: 325.
625.Kaplan, SR, Murkofsky, O. Oral-buccal dyskinetic symptoms associated with low dose benzodiazepine treatment. Am J Psychiatry 1978; 135: 1558–9.
626.Demetropoulos, S, Schauben, JL. Acute dystonic reactions from “street Valium”. J Emerg Med. 1987; 5: 293–7.
627.Lavenstein, BL, Cantor, FK. Acute dystonia: an unusual reaction to diphenhydramine. JAMA 1976; 236: 291.
628.Smith, RE, Domino, EF. Dystonic and dyskinetic reactions induced by HI antihistamic medication. In: Fann, WE, Smith, RC, Davis, JM, et al., eds. Tardive Dyskinesia: Research and Treatment, SP Medical and Scientific Books, NY 1980; pp 325–32.
629.Casteels-Van Daele, M, Eggermont, E, Casaer, P, Van de Casseye, W, De Boeck, K. Acute dystonic reactions and long-lasting impaired consciousness associated with oxatomide in children. Lancet 1: 1986; 1204–5.
630.Thatch, BT, Chase, TN, Bosma, JF. Oral dyskinesia associated with prolonged use of antihistaminic decongestants. N Engl J Med 1975; 293: 486–7.
631.Papini, M, Martinetti, MG, Pasquinelli, A. Tradodone symptomatic extrapyramidal disorders of infancy and childhood. Ital J Neurol Sci 1982; 3: 161–2.
632.Joske, DJL. Dystonic reaction to azatadine. Med J Australia 1984; 141: 449.
633.Powers, JM. Decongestant-induced blepharospasm and orofacial dystonia. JAMA 1982; 247: 3244–5.
634.Kaeser, HE. Parkinson therapy 1985. Schweiz Med Wochenschr 1986; 116: 801–4.
635.Lewith, GT, Davidson, F. Dystonic reactions to dimotapp elixir. J R. Coll Gen Pract 1981; 31: 241.
636.Nausieda, PA, Weiner, WJ, Klawans, HL. Dystonic foot response of Parkinsonism. Arch Neurol 1980; 37: 132–6.
637.Felser, JM, Orban, DJ. Dystonic reaction after ketamine abuse. Ann Emerg Med II 1982; 673–5.
638.Goetting, MG. Acute lithium poisoning in a child with dystonia. Pediatrics 1985; 76: 978–80.
639.Srikanth, S, Khanna, S, Channabasavanna, SM. Writer’s cramp associated with lithium. Clin Neuropharmacol 1988; 11: 189–90.
640.Susman, VL, Addonizio, G. Reinduction of neuroleptic malignant syndrome by lithium. J Clin Psychopharmacol 1987; 7: 339.
641.Arjona, JAM, Garcia, CA, Hoenigsfeld, LC, Pareja, FB. Early morning dystonia: a complication of levodopa therapy in Parkinson’s disease. Report of 4 cases. Med Clin 1984; 83: 4749.
642.Molina Arjona, JA, Arnal Garc’ia, C, Calandra Hoenigsfeld, L, Bermejo Pareja, F. Early morning dystonia: a complication of levodopa therapy in Parkinson’s disease. Presentation of 4 cases. Med Clin (Bare) 1984; 83: 47–9.
643.Peir’o Grasa, A, Grau-Veciana, JM. Secondary effects of prolonged levodopa therapy in Parkinson’s disease. Med Clin (Bare) 1985; 85: 8891.
644.Lees, AJ, Stern, GM. Bromocriptine in treatment of levodopa-induced end-of-dose dystonia. Lancet 2 1980; 215–6.
645.Umez-Eronini, EM, Eronini, EA. Chloroquine-induced involuntary movements. Br Med J 1 1977; 945–6.
646.Howrie, DL, Rowley, AH, Krenzelok, EP. Benztropine-induced acute dystonic reaction. Ann Emerg Med 1986; 15: 141–3.
647.Shafrir, Y, Levy, Y, Beharab, A, Nitzam, M, Steinherz, R. Acute dystonic reaction to bethanechol – a direct acetylcholine receptor agonist. Dev Med Child Neurol 1986; 28: 646–8.
648.Quinn, NP. Dystonia in epidemic ergotism. Neurology 1983; 33: 1267.
649.DiMonda, V, Fazzari, G, Callea, L, Almici, G. On a case of dystonia from manganism: therapeutic considerations. Acta Bio-Med 1979; 50: 317–20.
650.Hicks, CB, Abraham, K. Verapamil and myoclonic dystonia. Ann Inter Med. 1985; 103: 154. Medina, A, Biasini, O, Rivera, A, Sampera, A. Nifedipine and myoclonic dystonia. Ann Intern Med 1986; 104: 125.
652.Rosin, MA. Chlozoxazone-induced spasmodic torticollis. JAMA 1981; 246: 2575.
653.Nakano, T, Kondo, K, Oguchi, K, Yanagisawa, N, Nakano, T. A late onset case of paroxysmal dystonic choreoathetosis induced by caffeine and aminophylline. Rinsho Shinkeigaku 1983; 23: 199202.
654.Salminen, L, Jantti, V, Gronross, M. Blepharospasm associated with tegafur combination chemotherapy. Am J Ophthalmol 1984; 97: 649–50.
655.Rupniak, NMJ, Jenner, P, Marsden, CD. Acute dystonia induced by neuroleptic drugs. Psychopharmacology 1986; 88: 403–19.
656.Sramek, JJ, Simpson, GM, Morrison, RL, Heiser, JF. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study. J Clin Psychiatry 1986; 47: 305–9.
657.Shalev, A, Munitz, H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiat Scand 1987; 73: 337–47.
658.Pearlman, CA. Neuroleptic malignant syndrome: a review of the literature. J Clin Psychopharmacol 1986; 6: 257–73.
659.Friedman, JH, Davies, R, Wagner, RL. Neuroleptic malignant syndrome: a six-month prospective study in a state psychiatric hospital. Neurology 1988; 38(Suppl 1): 179.
660.Bateman, DN, Rawlins, MD, Simpson, JM. Extrapyramidal reactions with metoclopramide. Br Med J [Clin Res] 1985; 291: 930–2.
661.Bateman, DN, Rawlins, MD, Simpson, JM. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Q J Med 1986; 59: 549–56.
662.Keepers, GA, Casey, DE. Prediction of neuroleptic-induced dystonia. J Clin Psychopharmacol 1987; 7: 342–5.
663.Swett, C. Drug-induced dystonia. Am J Psychiatry 1975; 132: 532–4.
664.Chiles, JA. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics. Am J Psychiatry 1978; 135: 239–40.
665.Keepers, GA, Casey, DE. Clinical management of acute neuroleptic-induced extrapyramidal syndromes. Current Psychiat Therap 1986; 23: 139–57.
666.Boyer, WF, Bakalar, NH, Lake, CR. Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions. Clin Psychopharmacol 1987; 7: 164–6.
667.Winslow, RS, Stillner, V, Coons, DJ, Robinson, MW. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics. Am J Psychiatry 1986; 143: 706–10.
668.Manos, N, Lavrentiadis, G, Gkiouzepas, J. Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics. J Clin Psychiatry 1986; 47: 114–6.
669.McEvoy, JP, Simpson, GM. Dystonia, neuroleptic dose, and anticholinergic drugs. Am J Psychiatry 1987; 144: 393.
670.Kumor, Ket al.Haloperidol-induced dystonia in cocaine addicts. Lancet 2 1986; 1341–2.
671.Freed, E. Alcohol-triggered neuroleptic-induced tremor, rigidity and dystonia. Med J Aust 1981; 44–5.
672.Sovner, R, McGorrill, S. Stress as a precipitant of neuroleptic-induced dystonia. Psychosomatics 1982; 23: 707–9.
673.Malen, RL. The role of psychological factors in reversible, drug-related dystonic reactions. Mt Sinai J Med 1976; 43: 5670.
674.Flaherty, JA, Lahmeyer, HW. Laryngeal-pharyngeal dystonia as a possible cause of asphyxia with haloperidol treatment. Am J Psychiatry 1978; 135: 1414–5.
675.McDanal, CE Jr. Brief letter on case of laryngeal-pharyngeal dystonia induced by haloperidol, relieved by benztropine. Am J Psychiatry 1981 138: 1262–3.
676.Menuck, M. Laryngeal-pharygeal dystonia and haloperidol. Am J Psychiatry 1981 138: 394–5.
677.Ravi, SD, Borge, GF, Roach, FL. Neuroleptics, laryngeal-pharyngeal dystonia, and acute renal failure. J Clin Psychiatry 1982; 43: 300.
678.Holmes, VF, Adams, F, Fernandez, F. Respiratory dyskinesia due to antiemetic therapy in a cancer patient. Cancer Treatment Reports 1987; 71: 415.
679.Corre, KA, Niemann, JT, Bessen, HA. Extended therapy for acute dystonic reactions. Ann Emerg Med 1984; 13: 194197.
680.Gardos, G. Dystonic reaction during maintenance antipsychotic therapy. Am J Psychiatry 1981; 138: 114–5.
681.Keegan, DL, Rajput, AH. Drug induced dystonia tarda: treatment with L-dopa. Dis Nerv Syst 1973; 38: 167–9.
682.Bartels, M, Riffel, B, Stohr, M. Tardive dystonie: Eine seltene nebenwirkung nach Neuroleptika-Iangzeitbehandlung. Nervenarzt 1982; 53: 674–6.
683.Peatfield, RC, Spokes, EGS. Phenothiazine-induced dystonias. Neurology 1984; 34: 260.
684.Guy, N, Raps, A, Assael, M. The Pisa syndrome during maintenance antipsychotic therapy. Am J Psychiatry 1986; 143: 1492.
685.Gimenez-Roldan, S, Mateo, D, Bartolome, P. Tardive dystonia and severe tardive dyskinesia. Acta Psychiatr Scand 1985; 71: 488–94.
686.Friedman, JH, Kucharski, LT, Wagner, RL. Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry 1987; 50: 801–3.
687.Kwentus, JA, Schulz, SC, Hart, RP. Tardive dystonia, catatonia, and electroconvulsive therapy. J Nerv Mental Dis 1984; 172: 171–3.
688.Weiner, WJ, Nausieda, PA, Glantz, RH. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology 1981; 31: 1555–6.
689.Dilsaver, SC, Domino, L, Greden, JF. Meige’s syndrome of tardive dyskinesia? J Clin Psychopharmacol 1985; 5: 362–4.
690.Kang, UJ, Burke, RE, Fahn, S. Natural history and treatment of tardive dystonia. Movement Disorders 1986; 1: 193208.
691.Murray, JB. Neuroleptic malignant syndrome. J Gen Psychiatry 1987; 114: 3946.
692.Verhoeven, WMA, Elderson, A, Westenberg, HGM. Neuroleptic malignant syndrome: successful treatment with bromocriptine. Biol Psychiatry 1985; 20: 680–4.
693.Martin, DT, Swash, M. Muscle pathology in the neuroleptic malignant syndrome. J Neurol 1987; 235: 120–1.
694.Anon. 5-HT3 receptor antagonists: a new class of antiemetics. Lancet 1987; 2: 1470–1.
695.Allan, SG, Leonard, RCF, Cornbleet, MA, Smyth, JF. Dystonic reactions due to metoclopramide. Lancet 283, Feb 4 1984.
696.Arrowsmith, J, Gams, RA. Dystonia with droperidol therapy. New Engl J Med 1981; 305: 227.
697.Terrin, BN, McWilliams, NB, Maurer, HM. Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy. J Pediatrics 1984; 104: 138–40.
698.Bateman, DN, Craft, AW, Nicholson, E, Pearson, ADJ. Dystonic reactions and the pharmacokinetics of metoclopramide in children. Br J Clin Pharmac 1983; 15: 557–9.
699.Pollera, CF, Cognetti, F, Nardi, M, Mazza, D. Sudden death after acute dystonic reaction to high-dose metoclopramide. Lancet 2 1984; 460–1.
700.Hotson, JR, Langston, EB, Langston, JW. Saccade responses to dopamine in human MPTP-induced parkinsonism. Ann Neurol 1986; 20: 456–63.
701.Marsden, CD, Jenner, P. The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol Med 1980; 10: 5572.
702.Korczyn, AD. The pathophysiology of dystonia. J Neural Transmi 1978; 42: 245–50.
703.Parkes, JD, Bedard, P, Marsden, CD. Chorea and torsion in Parkinsonism. Lancet 1976; 1: 155.
704.Hallen, M. Bromocriptine for levodopa-induced end-of-dose dystonia. Lancet 1981; i1: 616.
705.Weiner, WJ, Nausieda, PA. Meige’s syndrome during long-term dopaminergic therapy in Parkinson’s disease. Arch Neurol 1982; 39: 451–2.
706.Wakayama, Y, Nakashima, Y, Tanaka, K, Mano, Y, Ando, F. Parkinson’s disease with diphasic dyskinesia and early-morning dystonia. Arch Neurol 1982; 39: 531.
707.Rondot, P, Bianco, C, de Recondo, J. Ageing and Parkinson’s disease. Gerontology 1986; 32(suppl 1): 102–5.
708.Quinn, NP, Lang, AE, Koller, WC, Marsden, CD. Painful Parkinson’s disease. Lancet 1986; 1: 708.
709.Kidron, D, Melamed, E. Forms of dystonia in patients with Parkinson’s disease. Neurology 1987; 37: 1009–11.
710.Curtis, L, Lees, A-J, Stern, G-M, Marmot, M-G. Effect of L-dopa on course of Parkinson’s disease. Lancet 2 1984; 211–2.
711.Friedman, A, Markowa, E. Involuntary movements as a complication of the treatment of extrapyramidal disorders with l-DOPA. Neurol Neurochir Pol 1981; 15:437–40.
712.Mendez, JS, Cotzias, GC, Mena, I, Parpavasiliou, PS. Diphenylhydantoin: blocking of levadopa effects. Arch Neurol 1975; 32: 44–6.
713.Chadwick, D, Reynolds, EH, Marsden, CD. Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry 1976; 39: 1210–8.
714.Goni, M, Jimenez, M, Feijoo, M. Parkinsonism induced by Phenytoin. Clin Neuropharmacol 1985; 8: 383–4.
715.Akindele, MO, Odejide, AO. Amodiaquine-induced involuntary movements. Br Med J 2 1976; 214–5.
716.Bhargava, RK, Parakh, LK, Hakim, A, Gori, MN, Bhardari, NC. Extra-pyramidal syndrome after antimalarials. J Assoc Physicians India 1973; 21: 969–73.
717.Singhi, S, Singhi, P, Singh, M. Chloroquine-induced involuntary movements. Br Med J 1977; 2: 520.
718.Bowen, WD, Walker, JM, Yashar, AG, Matsumoto, RR, Walker, FO, Lorden, JF. Altered haloperidol-sensitive σ receptors in the genetically dystonic (dt) rat. Eur J Pharmacol. 1988; 147: 153–4.
719.Gundlach, AL, Largent, BL, Snyder, SH. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)-[3H)3-(3-hydroxyphenyl)-N-(l-propyl)piperidine. J Neurosci 1986; 6: 1757–70.
720.Weber, E, Sonders, M, Quarum, M, McLean, S, Pou, S, Keanna, JFW. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels σ type receptors for psychomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 1986; 83: 8784.
721.Walker, JM, Matsumoto, RR, Bowen, WD, Gans, DL, Jones, KD, Walker, FO. Evidence for a role of haloperidol-sensitive σ “opiate” receptors in the motor effects of anti-psychotic drugs. Neurology 1988; 38: 961–5.
722.McKeon, TW, Lorden, JF, Oltmans, GA, Beales, M, Walkley, SU. Decreased catalepsy response to haloperidol in the genetically dystonic (dt) rat. Brain Res 1984; 308: 8996.
723.McKeon, TW, Lorden, JF, Beales, M, Oltmans, GA. Alterations in the noradrenergic projection to the cerebellum of the dystonic (dt) rat. Brain Res 1986; 366: 8997.
724.Lorden, JF, McKeon, TW, Baker, HJ, Cox, N, Walkley, SU. Characterization of the rat mutant dystonic (dt): a new animal model of dystonia musculorum deformans. J Neurosci 1984; 4: 1925–32.
725.Oltmans, G, Beales, M, Lorden, J. Glutamic acid decarboxylase activity in micropunches of the deep cerebellar nuclei of the genetically dystonic (dt) rat. Brain Res 1986; 385: 148–51.
726.Oltmans, GA, Beales, M, Lorden, JF, Gordon, JH. Alterations in cerebellar glutamic acid decarboxylase (GAD) activity in a genetic model of torsion dystonia (rat). Exp Neurol 1984; 85: 216–22.
727.Lorden, JF, Oltmans, GA, McKeon, TW, Lutes, J, Beales, M. Decreased cerebellar 3’,5’-cyclic guanosine monophosphate levels and insensitivity to harmaline in the genetically dystonic rat (dt). J Neurosci 1985; 5: 2618–25.
728.Lutes, J, Lorden, JF, Oltmans, GA. Effects of Clonidine on the motor syndrome of the genetically dystonic rat. Soc Neurosci Abstr 1985; 11: 670.
729.Duchen, LW, Strich, ST, Falconer, DS. Clinical and pathological studies of an hereditary neuropathy in mice (dystonia musculorum). Brain 1964; 87: 367–78.
730.Moss, TH. Segmental demyelination in the peripheral nerves of mice affected by hereditary neuropathy (Dystonia Musculorum). Acta Neuropatholol 1981; 53: 51–6.
731.Moss, TH, Lewkowicz, SJ. A comparative scanning electron microscopical study of endoneurial collagen around normal mouse nerve fibres, nerve fibres following crush injury and nerve fibres of the dystonic mouse mutant (dt/dt). Cell Tissue Res 1981; 220: 881–7.
732.Hanker, JS, Ambrose, WW, Yates, PE, Koch, GG, Carson, KA. Peripheral neuropathy in mouse hereditary diabetes mellitus. Acta Neuropathol (Bed) 1980; 51: 145–53.
733.Moss, TH. Schwann cell involvement in the neurological lesion of the dystonic mutant mouse. J Neurol Sci 1981; 49: 207–22.
734.Messer, A, Gordon, D. Changes in whole tissue biosynthesis of γ-aminobutyric acid (GABA) in basal ganglia of the dystonia (dtALb) mouse. Life Sci 1979; 25: 2217–21.
735.Riker, DK, Messer, A, Roth, RH. Increased noradrenergic metabolism in the cerebellum of the mouse mutant Dystonia Musculorum. J Neurochem 1981; 37: 649–54.
736.Messer, A. Amino acid changes in the mouse mutant dystonia musculorum deformans similar to those in Friedreich’s ataxia. Can J Neurol Sci 1982; 9: 185–8.
737.Ebendal, T, Lundin, LG. Nerve growth factor in three neurologically deficient mouse mutants. Neurosci Lett 1984; 50: 121–6.
738.Messer, A, Strominger, NL. An allele of the mouse mutant dystonia musculorum deformans exhibits lesions in red nucleus and striatum. Neuroscience 1980; 5: 543–9.
739.Stanley, E, Messer, A, Strominger, NL. Effects of age and strain differences on the red nucleus of the mouse mutant dystonia musculorum. Anat Rec 1983; 206: 313–8.
740.Gopalakrishnakone, P. Pathological features of idiopathic torticollis in the duck – a model for human disease. J Comp Path 1984; 94: 453–62.
741.Gopalakrishnakone, P. Animal model of human disease: idiopathic torticollis. Torticollis in white Pekin duck. Am J Path 1985; 118: 500–1.
742.Clarke, CE, Sambrook, MA, Mitchell, IJ, Crossman, AR. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP). J Neurol Sci 1987; 78: 273–80.
743.Kistrup, K, Gerlach, J. Selective Dl and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans. Pharmacol Toxicol 1987; 61: 157–61.
744.Meldrum, BS, Anlezark, GM, Marsden, CD. Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain 1977; 100: 313–26.
745.Casey, DE, Gerlach, J, Christensson, A. Dopamine, acetylcholine and GABA effects in acute dystonia in primates. Psychopharmacol 1980; 70: 83–7.
746.Neale, R, Gerhardt, S, Liebman, JM. Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys. Psychopharmacol 1984; 82: 20–6.
747.Murphey, DL, Dill, RE. Chemical stimulation of discrete brain loci as a method of producing dyskinesia models in primates. Exp Neurol 1972; 34: 244–54.
748.Cools, AR, Hendriks, G, Korten, J. The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic, dystonic, dyskinetic, and epileptoid motor activities. J Neural Transm 1974; 36: 91105.
749.Haggstrom, JE. Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys. Acta Psychiatr Scand (Suppl) 1984; 311: 103–8.
750.Povlsen, UJ, Noring, U, Laursen, AL, et al.Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in cebus monkeys. Clin Neuropharm 1986; 9: 8490.
751.Bedard, P, Delean, J, Lafleur, J, Larochelle, L. Haloperidol-induced dyskinesias in the monkey. Can J Neurol Sci 1977; 4: 197201.
752.Paulson, GW. Dyskinesias in monkeys. Adv Neurol 1973; 1: 647–50.
753.Mones, RJ. Experimental dyskinesias in normal rhesus monkeys. Adv Neurol 1973; 1: 665–9.
754.Sassin, JF. Drug-induced dyskinesia in monkeys. Adv Neurol 1973; 1: 4754.
755.Heintz, R, Casey, DE. Pargyline reduces/prevents neuroleptic-induced. acute dystonia in monkeys. Psychopharmacology 1987; 93: 207–13.
756.Liebman, J, Neale, R. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacol 1980; 68: 25–9.
757.Liebman, JM. Tetrabenazine and dystonia in primates. Ann Neurol 1986; 19: 203–4.
758.Neale, R, Gerhardt, S, Fallon, S, Liebman, JM. Progressive changes in the acute dyskinetic syndrome as a function of repeated elici-tation in squirrel monkeys. Psychopharmacol 1982; 77: 223–8.
759.Haggstrom, JE, Anderson, U, Gunne, LM. A primate model for tardive dyskinesia: postmortem biochemical findings. In: Perris, C, Struwe, G, Jansson, G, eds., Developments in Psychiatry, vol. 5, Biological Psychiatry. Elsevier/North Holland, Biomedical Press, Amsterdam, 1981; pp 837–9.
760.Gunne, L-M, Barany, S. Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 1976; 50: 237–40.
761.Cadet, JL. Participation of the serotonin2 receptor in the imin-odipropionitrile-induced dyskinetic syndrome. Exp Neurol 1988; 99: 589–93.
762.Gray, LE Jr, Rogers, JM, Kavlock, RJ, Ostby, JS, Ferrell, JM, Gray, KL. Prenatal exposure to the fungicide dinocap causes behavioral torticollis, ballooning and cleft palate in mice, but not in rats or hamsters. Teratogen Carcinogen Mutagen 1986; 6: 3343.
763.Cutting, W, Furst, A, Read, D, Read, G, Parkman, H. Circling syndrome produced by dimethylaminohexose reductone. Proc Soc Exp Biol Med 1960; 104: 381–5.
764.Read, D, Furst, A, Cutting, W. Effect of chlorpromazine and thiouracil on the circling syndrome produced in mice by dimethylaminohexose reductone. Stanford Med Bull 1960; 18: 125–8.
765.Kunstyr, I, Naumann, S, Kaup, F-J. Torticollis in cats: etiology, pathology, diagnosis and therapy. Beri Munch Tierarztl Wochenschr 1986; 99: 14–9.
766.Burke, RE, Fahn, S. Electroencephalographic studies of chlorpromazine methiodide and somatostatin-induced barrel rolling in rats. Exp Neurol 1983; 179: 704–13.
767.Burke, RE, Fahn, S. Chlorpromazine methiodide acts at the vestibular nuclear complex to induce barrel rotation in the rat. Brain Res 1983; 288:273–81.
768.Rotrosen, J, Stanley, M, Kuhn, C, Wazer, D, Gershon, S. Experimental dystonia induced by quaternary-chlorpromazine. Neurology 1980; 30: 878–81.
769.Mori, K, Shimabukuro, H, Yamashiro, K, Miyake, H, Kawano, T. Spasmodic head movements produced by destruction of unilateral ventromedial tegmentum in cats. Appi Neurophysiol 1985; 48: 347–50.
770.Arushanyan, EB, Dutov, AA. Effect of DOPA and haloperidol on experimental mesencephalic torticollis and its modulation by caudate nucleus stimulation. Farmakol Toksikol 1983; 46: 24–8.
771.Malouin, F, Bedard, PJ. Frontal torticollis (head tilt) induced by electrolytic lesion and kainic acid injection in monkeys and cats. Exp Neurol 1982; 78:551–60.
772.Malouin, F, Bedard, PJ. Evaluation of head motility and posture in cats with horizontal torticollis. Exp Neurol 1983; 81: 559–70.
773.Fukushima-Kudo, J, Fukushima, K, Tashiro, K. Rigidity and dorsiflexion of the neck in progressive supranuclear palsy and the interstitial nucleus of Cajal. J Neurol Neurosurg Psychiatry 1987; 50: 11971203.
774.Jacquet, YF, Abrams, GM. Postural asymmetry and movement dis-order after unilateral microinjection of adrenocorticotropin 1-24 in rat brainstem. Science 1982; 218: 175–7.
775.Jacquet, YF. “Dystonia”-like postural asymmetry after microinjection of ACTH N-terminal fragments but not after ACTH 1-39 in rat brainstem suggests role of neuropeptide mutation in genetic movement disorders. Brain Res 1984; 294: 144–7.
776.Sandyk, R, Consroe, P. The relationship of peripheral trauma and pain to dystonia. J Neurol Neurosurg Psychiatry 1986; 49: 845.
777.Imperato, A, Nicoletti, F, Diana, M, Scapagnini, U, Di Chiara, G. Fastigial influences on postural tonus as studied by kainate lesions and by local infusion of GABAergic drugs in the rat. Brain Res 1984; 295: 5163.
778.Sambrook, MA, Crossman, AR, Slater, P. Experimental torticollis in the mormoset producd by injection of 6-hydroxydopamine into the ascending nigrostriatal pathway. Exp Neurol 1979; 63: 583–93.
779.McGeer, PL, McGeer, EG. Intracerebral injections of kainic acid and tetanus toxin: possible models for the signs of chorea and dystonia. Adv Neurol 1978; 21: 331.
780.Stoddart, JC. Pseudotetanus. Anesthesia 1979; 34: 877–81.
781.D’Angelo, LJ, Beary, JF III, Stair, T. Tetanus mimicking “pseudotetanus”. South Med J 1984; 77: 1052.
782.Crossman, AR, Sambrook, MA, Jackson, A. Experimental hemi-chorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia brain. Brain 1984; 107: 579–96.
783.McGeer, PL, Itagaki, S, McGeer, EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropath 1988; (in press).
784.Sandyk, R, Iacono, RR, Bamford, CR. Hypothalamic dysregulation of immune responses in focal dystonia. Acta Neurol Scand 1987; 75: 440.
785.Mizukawa, K, McGeer, PL, Tago, H, Peng, JH, McGeer, EG, Kimura, H. The cholinergic system of the human hindbrain studied by choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Brain Res 1986; 379: 3955.
786.Vincent, SR, Satoh, K, Armstrong, DM, Panula, P, Vale, W, Fibiger, HC. Neuropeptides and NADPH-diaphorase activity in the ascending cholinergic reticular system of the rat. Neuroscience 1986; 17: 167–82.